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Glucose plays an important role in stem cell fate determination 
and its behavior. Stem cell fate is regulated by genes involved in 
differentiation, proliferation, and migration. Previous investigators 
have suggested that oxidative stress, especially reactive oxygen 
species (ROS), increases stem cell migration and the increase of 
ROS may destroy the homeostasis of the cells, and subsequently 
serious damage in the cells. High glucose is the cause of excess 
ROS that leads to diabetic complications. 17β-estradiol (E2) is an 
important regulator of energy homeostasis and glucose metabolism, 
so that it should be considered a suitable target of E2 for preventing 
or treating metabolic disorders. Diabetes is closely related to 
oxidative stress and the risk of diabetes is high in patients who are 
deficient in E2. Thus, E2 has protective roles against oxidative 
stress exposure which leads to mitochondrial dysfunction and 
damage. However, it remains unclear how glucose contributes to 
the precise molecular mechanism for producing ROS in the stem cell 
and E2 evokes protective antioxidant mechanisms. Therefore, 
present study aimed to investigate 1) the effect of high glucose on 
stem cell migration and its related signaling pathways, 2) the role of 
E2 in glucose-mediated mitochondrial ROS (mtROS) level in human 
umbilical cord blood-derived mesenchymal stem cells (hUCB-
MSCs), and 3) the effect of hUCB-MSC transplantation on mouse 





First, I investigated the effect of high glucose on regulation of 
hUCB-MSC migration. High glucose treatment (D-glucose) 
induced hUCB-MSC migration, expression of cleaved Notch, Snail 
and enhancer of zeste homolog2 (EZH2), but repressed epithelial 
cadherin (E-cadherin) expression. E-cadherin repression was 
regulated by high glucose through Snail and EZH2 upregulation, and 
Snail was modulated in parallel with EZH2 in hUCB-MSCs. Next, I 
demonstrated that high glucose enhanced ROS, which activates 
either c-Jun N-terminal kinase (JNK) or phosphatidylinositol-3-
kinses (PI3K)/protein kinase B (Akt) signaling. High glucose-
induced JNK activation elicit the cleavage of Notch protein through 
γ–secretase activation, following Notch intracellular domain (NICD) 
translocation into the nucleus. In the nucleus, Snail interacted with 
polycomb repressive complex 2 (PRC2) components by high 
glucose. And then EZH2, one of the major component of PRC2, and 
Snail bound with E-box of the E-cadherin promoter by high 
glucose, which in turn causes E-cadherin repression. Taken 
together, these results suggest that high glucose-induced ROS 
production increases the migration of hUCB-MSCs through E-
cadherin repression via EZH2 and Snail upregulation.  
Next, I investigated the role of E2 on mtROS-mediated 




increased mtROS to upregulate Beclin1 and LC-II expression, 
leading to decreased cell viability. In contrast, E2 treatment 
significantly decreased high glucose-induced mtROS levels and 
subsequently restored cell viability, suggesting that E2 serves as a 
strong antioxidant. I found that treatment of both E2 and high 
glucose promoted ERα translocation into the nucleus leading to 
increased Nrf2 in the nucleus. However, high glucose produced 
mtROS via downregulating Nrf2 nuclear translocation. This 
subsequently culminated in Sirtuin3 (Sirt3) downregulation and 
manganese superoxide dismutase (MnSOD) acetylation. The 
increased nuclear translocation of Nrf2 triggered upregulation of 
Sirt3 expression and activated MnSOD; both of which play 
important roles in decreasing mtROS. The therapeutic effect of 
hUCB-MSC transplantation on skin wound healing for OVX diabetic 
mice was enhanced by E2 treatment when compared to the mice 
without E2 treatment. In addition, the blood vessels that had well-
developed branches were observed in OVX diabetic mice that 
received hUCB-MSC transplantation with E2 when compared to 
ERα siRNA-transfected hUCB-MSC transplantation. 
In conclusion, present study presented that 1) high glucose-
induced ROS stimulates the hUCB-MSC migration through E-
cadherin repression via Snail and EZH signaling pathways, and 2) 




production and autophagic cell death through ERα-dependent Nrf2, 
followed by subsequent Sirt3 upregulation and MnSOD activation.  
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1. Stem cells 
 
A. Definition of stem cells 
Stem cells are undifferentiated cells with self-renewal ability. 
They have the capacity to produce functionally several 
differentiated cells (Weissman et al., 2001; Smith, 2001). Stem 
cells are classified based on their differentiation potential; totipotent, 
pluripotent and multipotent stem cells. Totipotent stem cells have 
unlimited capability to form all lineages of an organism. Pluripotent 
stem cells are capability of differentiating into almost all cell types, 
which are derived from ectoderm, mesoderm and endoderm. 
Multipotent stem cells have potential to form cells that are 
restricted to organ sources. In mammals, there are two types of 
stem cells: embryonic stem cells (ESCs) and adult stem cells. ESCs 
are derived from inner cell mass of blastocysts. Whereas, adult 
stem cells are derived from adult tissues such as adipose, bone, and 
umbilical cord blood (UCB), which offer easy source for use in 
research and therapy in vivo. Taken together, stem cells can be 
described as having replication ability, which is the capacity of 
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B. Embryonic stem cells 
ESCs are derived from the inner cell mass of the blastocyst of the 
preimplantation embryo at the early stage and has the potential to 
differentiate into all cell types. The basic characteristics of ESC are 
self-renewal, multilineage differentiation, clonality, and normal 
karyotype. ESCs have potential to differentiate into three germ 
layers (ectoderm, mesoderm, and endoderm). Pluripotency of ESCs 
distinguishes themselves from adult stem cells that can differentiate 
into restricted cell types. In order to maintain the ESCs 
undifferentiated, the cells should be cultured on the feeder layer or 
in the presence of leukemia inhibitory factor (LIF). LIF may affect 
cell proliferation or cell cycle progression rate. In addition, LIF can 
also act on the stem cell phenotype by activating signaling cascade 
by regulating genes expressed only in pluripotent and differentiated 
cells. Basic fibroblast growth factor (bFGF) is required for self-
renewal of human ESCs through Activin/Nodal signaling-regulated 
OCT4 expression (Honda et al., 2009), and feeder layer, 
conditioned medium and cytokines are essential under human ESC 
culture system. Moreover, bone morphogenetic protein 4 (BMP4), 
along with LIF, has been shown to be a growth factor that maintains 
self-renewal of ESCs and blocks neural differentiation (Ying et al, 
2003). Human ESCs have similar markers and expression patterns, 
but some of them exhibit the same pattern as mouse ESCs. In 
  
- 4 - 
 
mouse ESCs, Stage-specific embryonic antigen (SSEA) 1 is 
considered as undifferentiated marker, whereas in human ESCs, the 
increase in SSEA1 is closely related to differentiation. Because of 
the unlimited self-renewal capacity of ESCs, it has been suggested 
as an alternative source for regenerative medicine and tissue 
replacement. Furthermore, ESCs also play a role as tools for 
genetic studies and toxicity testing (Thomson et al., 1998). 
However, safety issues including teratoma formation must be 
addressed first in order for ESCs to be used extensively in clinical 
environments. Therefore, further studies are needed to establish 
strategies to improve ESCs therapy safety. 
 
C. Mesenchymal stem cells 
Adult stem cells (also known as somatic stem cells) are 
undifferentiated cells that are found in the body after development. 
The basic characteristics of adult stem cells are their ability to 
differentiate and self-renew. Adult stem cells can be isolated from 
most tissues of the body, including bone marrow, fat, human 
umbilical cord and placenta tissue. There are various types of adult 
stem cells including hematopoietic, mammary, intestinal, 
mesenchymal, endothelial, and neural stem cells.  
Mesenchymal stem cells (MSCs) are multipotent stem cells that 
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possess self-renewal ability and exist in almost all tissues. They 
also have the potential to differentiate into distinct mesenchymal 
cells, including osteoblasts, adipocytes, chondrocytes, myoblasts, 
and neural cells (Pittenger et al., 1999; Barry and Merphy, 2004), 
but are not capable of reconstituting the entire organ. Due to 
various limitations in ESCs and induced pluripotent stem cells 
(iPSCs) research such as teratoma formation, immune rejection, 
political and ethical restrictions, MSCs are a very attractive 
candidate for tissue repair and gene therapy because of their ability 
to migrate to places where they are needed. Among other MSCs, 
MSCs derived from umbilical cord blood are known to regulate the 
immune system, reduce inflammation, and secrete factors 
necessary to improve regeneration of various tissues of the body. 
In particular, hUCB-MSCs accelerate wound healing through 
angiogenesis and differentiation, which can improve therapeutic 
potential in the treatment of clinical diseases (Chang et al., 2016; 
Lee et al., 2016; Ryu and Han, 2015). Thus, the use of hUCB-
MSCs in stem cell-based therapies has been regarded as a future 
medicine that can provide new potential for regenerative medicine, 
but further studies of hUCB-MSCs are needed to develop more 
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2. Glucose as a stem cell regulator 
 
A. Glucose metabolism 
Glucose represents important regulatory elements that modulate 
cell fate determination in both physiological and pathological states. 
Glucose also plays a role in maintaining the function of stem cells, 
and glucose metabolism regulates the balance between the 
quiescence and proliferation of stem cells. Proliferation of the cells 
depends on the significant ATP production, which is normally 
maintained through oxidative phosphorylations (OXPHOS). Glucose 
molecules metabolized by OXPHOS can provide the energy 
necessary for maintaining protein synthesis, proliferation, and 
migration. However, stem cells do not depend solely on OXPHOS. 
Previous studies have shown that oxygen consumption in stem cells 
decreases and the acidity of the medium is independent of glucose 
uptake (Zhang et al., 2011). Stem cells depend on glycolysis rather 
than OXPHOS to produce the energy needed for homeostasis 
(Simsek et al., 2010). In addition, the pluripotency of stem cells is 
closely correlated with glucose metabolism (Figure 1). Excessive 
exposure to glucose can produce more ATP than OXPHOS via 
glycolysis (Guppy et al., 1993) that results in metabolic changes in 
stem cells. Many researchers reported that high glucose induces 
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the variety of responses in stem cells, such as proliferation, 
senescence, migration, and apoptosis (Li et al., 2007; Cramer et al., 
2010). Changes in glucose homeostasis can have serious 
consequences on the ability of stem cells to self-renew and 
differentiate themselves, as changes in cellular metabolism occur 
earlier than stemness changes (Folmes et al., 2011; Ochocki and 
Simon, 2013). Thus, these findings suggest that the regulation of 
intracellular glucose signaling has an ability to control the 
metabolism and behavior of stem cells.  
 
B. Glucose transporters 
Glucose is the major substrate for energy source, which is 
transported in the blood of animal. Blood glucose is maintained at a 
constant level by two substances, insulin and glucagon, produced in 
the pancreas. Increased glucose concentration in the blood causes 
glucose metabolism syndrome including diabetes mellitus, diabetic 
ketoacidosis, and hyperosmolar coma. Diabetes is a metabolic 
disorder characterized by decreased glucose tolerance due to 
insulin secretion or dysfunction for glycemic control. As the blood 
glucose level rises abnormally, glucose flows into the urine which is 
also called glucosuria. Type 1 diabetes is caused by an absolute 
deficiency of insulin and type 2 diabetes is caused by impaired 
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insulin function. Glucose tolerance is also reduced in type 2 
diabetes due to impaired tissue sensitivity to insulin action. Recent 
studies have shown that microvascular damage by diabetes is 
directly related to the degree of hyperglycemia and duration of 
diabetes. The concentration of blood glucose in people with non-
diabetes is maintained between 4.5–5.5 mmol/L, which fluctuates 
throughout the day. However, according to the American Diabetes 
Association, the target range for blood glucose in diabetic patients 
should not exceed 5–7.2 mmol/L before meal and up to 10 mmol/L 
after meal. Diabetes mellitus is considered to be diabetes if the 
blood glucose level is higher than 11.1 mmol/L 2 hours after food 
intake. If the blood glucose level is above 25 mmol/L, the risk of 
diabetic complications increases. If it is higher than 33.3 mmol/L, it 
may cause hyperosmolar syndrome and lead to dehydration and 
diabetic coma. Thus, blood glucose control is essential to prevent 
diabetes and its complications.  
Maintaining a stable level of glucose in the blood is one of the 
important mechanisms to maintain cell homeostasis. Glucose 
transporters have two main types: glucose transporter (GLUT) and 
sodium-dependent glucose cotransporters (SGLTs). GLUTs are 
facilitative transport proteins involved in glucose translocation 
across the cell membrane. It undergoes structural changes 
transported into the cells of glucose when they bind together. 
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Among all GLUTs, GLUT1-4 are the major glucose receptors and 
most widely studied. GLUT2 has a low affinity for glucose because 
it has a high Km value (15-25 mmol/L), and the rate of glucose 
uptake is proportional to the amount of glucose. GLUT4 is activated 
when insulin binds to the insulin receptor, and is primarily found in 
adipose and muscle tissues. The Km values of GLUT1 and GLUT3 
are similar or lower than the basic blood glucose in humans (4.5-
5.5 mmol/L), so they have high affinity for glucose and are 
constantly absorbed from the bloodstream. When blastomere is 
differentiated into trophectoderm and pluripotent inner cell mass, 
metabolic activity increases steeply. ESCs that are derived from 
inner cell mass of blastocyst upregulate the expression of GLUT1 
and GLUT3 to increase glucose uptake. Thus, glycolytic flux 
increases rapidly and lactate synthesis increases. However, when 
stem cells differentiate, the glycolytic flux decreases sharply and 
the expression of GLUT1 and GLUT3 decreases. Decreased 
expression of GLUT1 and GLUT3 under stress circumstances 
reduces glucose uptake in MSCs, meaning glucose metabolic profile 
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C. ROS and stem cell fate 
ROS are mainly produced by mitochondria, endoplasmic reticulum, 
and plasma membranes. Mitochondrial ROS is mainly present in 
three forms: superoxide anion (O2-), hydrogen peroxide (H2O2), 
and hydroxyl radical (OH-). O2- includes non-covalent electrons 
that confer high reactivity and require rapid reduction to H2O2 by 
antioxidant enzyme superoxide dismutase (SOD) (Figure 2).  H2O2 
can be reduced by various cellular antioxidants including SOD and 
catalase that eliminate ROS production.  
For both development and tissue homeostasis, proper balance 
between self-renewal and differentiation is important for stem cell 
function. Recent studies of pluripotent stem cells and adult stem 
cells demonstrate that this balance is partially regulated by ROS 
that mediates the cellular redox state (Wang et al, 2013). ROS 
directly interacts with various proteins such as kinase, phosphatase, 
or transcription factor to alter the process of regulating cell cycle 
progression, apoptosis and differentiation. In particular, high ROS 
levels can promote stem cell motility after acute stress situations, 
meaning that the production of ROS results in stem cell migration 
and invasion. High glucose is especially crucial for stem cell 
function through ROS-mediated PI3K/Akt activation (Kim et al., 
2006). Elevated ROS production mediates self-renewal and 
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neurogenesis by PI3K/Akt signaling in neural stem cells (Le Belle 
et al., 2011). Thus, these findings suggest that ROS can be 
considered to be a signaling molecule that participates in cross talk 
between metabolism and stem cell fate determinations.  
 
D. Autophagy and ROS 
Mitochondria are the principal source of ROS for inducing 
autophagy (Murphy, 2009; Scherz-Shouval et al., 2007). 
Autophagy allows the degradation and recycling of cellular 
components under various stressful conditions such as excess of 
ROS to maintain intracellular homeostasis during protein and 
organelle turnover (Rosa et al., 2016). In addition, ROS by oxidative 
stress induces cell death, but antioxidants contribute to autophagic 
clearance of oxidized biomolecules (Giordano et al., 2013). 
However, impaired autophagy can be caused by hyperglycemia, 
which can lead to the accumulation of unfolded proteins and 
dysfunctional organelles in the cells. This implies that autophagy 
plays a role in the pathology and physiology of diabetic 
complications (Volpe et al., 2018). Exposure to high glucose affects 
cell death by autophagy dysfunction (Wang et al., 2015). In addition, 
it has been reported that high glucose-induced oxidative stress 
regulates autophagy through mitochondrial damage (Park and Park, 
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2013). Thus, reduced autophagy dysfunction may prevent oxidative 
stress-induced, diabetes-associated diseases. However, it remains 
unknown that which modulator by oxidative stress contributes to 
high glucose-evoked autophagy in stem cells. Therefore, further 
investigation into the role of ROS in stem cell physiology and 
metabolism under high glucose conditions is needed for the 

















Figure 1. Glucose metabolism in stem cells. The schematic model 
shows the glucose metabolic in stem cells. Stem cells rely on 
glycolysis rather than OXPHOS to produce the energy needed for 
homeostasis. GLUT, glucose transporter; G6P, glucose 6-
phosphate; F6P, fructose 1,6-bisphosphate; ETC, electron 
transport chain; TCA, tricarboxylic acid; NADH, nicotinamide 
adenine dinucleotide; ATP, adenosine triphosphate; HK, hexokinase; 









Figure 2. Production and scavenging of mitochondrial ROS. The 
schematic model indicates that superoxide (O2•-) is produced from 
the O2 molecule, that can be also produced from complexes I and III 
in mitochondria. H2O2 is catalyzed by SOD enzyme, which can be 
further reduced to H2O molecule by catalase enzyme. FMN, Flavin 
mononucleotide; FAD, Flavin adenine dinucleotide; Cyt, cytochrome; 
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3. Wound healing  
 
A. Stem cells in wound healing mechanism 
Wound healing is a natural recovery process for tissue damage, 
which involves restructuring and restoring the injured skin through 
complex cellular cascade events. Wound healing is divided into four 
phases: hemostasis, inflammatory, proliferation, and remodeling 
(Figure 3). The initial wound shrinks and blood coagulates in the 
blood vessels showing characteristic signs of inflammation. In the 
proliferation phase, wound sites are filled with new granulation 
tissues and angiogenesis is followed. In the maturation phase of 
wound healing, the wound is observed to be closed. Cell activity is 
reduced and the number of blood vessels at the wound site is 
decreased. During wound healing process, cells often migrate 
through cell-cell junction (Li et al., 2013). In addition, epithelial 
cells proliferate and migrate to the center of wound sites while the 
wound heals. Migration plays an essential role when cells are in 
stable connections. Epithelial cells are tightly connected by cell-
cell adhesion molecules, including E-cadherin. Stem cells are an 
attractive candidate to enhance the therapeutic potential for 
cutaneous wound healing and tissue regeneration due to secretion 
of various cytokines, including vascular endothelial growth factor 
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(VEGF), epidermal growth factor (EGF), and keratinocyte growth 
factor. In wound proliferation stages, fibroblasts show phenotypic 
switch toward myofibroblasts as a typical characteristic of wound 
healing process (Siebert et al., 2011; Hinz, 2007). Stem cells 
secrete various cytokines and paracrine factors as well as migration 
and proliferation to the wound, which can affect the 
microenvironment and increase tissue repair and angiogenesis. 
Stem cells differentiate into keratinocytes which are activated by 
pro-inflammatory cytokines and growth factors, and then migrate 
to wound sites. Activated keratinocytes communicate with other 
cells and cause reepithelization (Figure 4). The effect of MSC 
transplantation on tissue regeneration was induced by the paracrine 
effect rather than cell replacement, and the migration of the 
transplanted cells to the wound site was reported to be related to 
wound healing process initiation and immune regulatory processes 
(Granero-Molto et al., 2009; Kwon et al., 2013). However, many 
researchers revealed that MSCs are a key factor of regenerative 
wound healing because MSCs contribute to the secretion of growth 
factors that promotes neovascularization and reepithelization (Balaji 
et al.,2012; Lee et al., 2016). Furthermore, MSCs enhance wound 
healing by structural repair through cellular differentiation (Kanji 
and Das, 2017). Based on these findings, further studies for 
successful stem cell therapy will be needed to improve the 
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therapeutic effect of MSCs in wound healing and tissue regenerative 
medicine.  
 
B. Role of E-cadherin in stem cell migration 
E-cadherin is a crucial component of cell adhesion molecules that 
perform the formation of cell-cell adherens junctions to bind cell 
via a hemophilic mechanism (Takeichi, 1991). In particular, the role 
of E-cadherin is critical in maintaining the adhesion of cells and in 
the formation of specialized cell-cell junctions (Shirayoshi et al., 
1983; Boller et al., 1985). The cadherin-based adherens junctions 
interact with α–catenin and β–catenin, which are involved in the 
cytoskeleton network, to form a stable adherens junctions (Drees et 
al., 2005). In addition, the interaction between E-cadherin and β–
catenin modulates actin-filament assembly (Drees et al., 2005). 
However, during dissolution of adherens junctions, E-cadherin can 
no longer interact with β–catenin, resulting in the reduction of 
adhesion and increase in cell motility (Christofori and Semb, 1999). 
The processes of cell migration involve four major parts including 
extension, adhesion, translocation and detachment. Cells are tightly 
attached to other cells or to the extracellular matrix and need to 
detach by disrupting the cell-cell interaction in order to migrate. 
Therefore, cell-cell detachment-related events are much 
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emphasized while cell migration processes occur through the 
down-regulation of adhesion molecules. Many researchers have 
studied that detachment is important during cell migration by which 
adhesions disassemble (Palecek et al., 1998; Webb et al., 2002; 
Kirfel et al., 2004).  
The metabolic function and migration capacity of stem cells are 
essential in maximizing their therapeutic benefits. Several studies 
have mentioned that stem cells enhance the efficacy of migration to 
the target tissue for stem cell-based therapies (Horwitz et al., 
1999; Sohni and Verfaillie, 2013). E-cadherin is the most studied 
molecule for adhesion of stem cells. E-cadherin accumulates 
between stem cells and niche cells (Song and Xie, 2002). When E-
cadherin is removed from stem cells, the stem cells rapidly detach 
from the niche cells (Song et al., 2002; Song and Xie, 2002). 
Moreover, E-cadherin overexpression inhibited stem cell migration 
whereas E-cadherin inhibition enhanced stem cell migration (Chen 
et al, 2015). Combined with the results, E-cadherin is the crucial 
roles in the interaction of stem cells and niche cells as well as stem 
cell migration. However, the precise mechanisms by which E-
cadherin regulates stem cell migration and improves the efficacy of 
stem cell-based therapies have not been established. 
 
  




Figure 3. Four stages of wound healing process. The schematic 
model indicates that wound healing is divided into four stages: 










Figure 4. Role of stem cells in wound healing. The schematic model 
indicates that stem cells differentiate into keratinocytes that are 
activated by pro-inflammatory cytokines and growth factors. 
Activated keratinocytes migrate to the wound site and communicate 









- 21 - 
 
4. Diabetes and menopause 
 
A. The relationship between E2 and hyperglycemia 
E2, a well-known female steroid hormone, plays important roles 
in regulating the processes of many tissues that participate 
reproductive physiology, cardiovascular, skeletal and central nerve 
system (Murphy, 2011; Cersosimo and Benarroch, 2015; Wend et 
al., 2012). In addition, E2 has recently been shown to play 
important roles in physiological and pathological aspects in not only 
women but also in men. However, endogenous sex hormones, 
insulin resistance, visceral obesity, sleep disorder and depression, 
all of which contribute to risk factors for diabetes have been shown 
to change in postmenopausal women with E2 deficiency. 
Furthermore, middle-aged women are more at risk for diabetes 
than younger women. Indeed, early menopausal women are at high 
risk of incidence of type 2 diabetes because of more prolonged E2 
deficiency (Brand et al., 2013). Many studies demonstrated that 
postmenopausal hormone therapy has been studied to improve 
glucose homeostasis and body composition in clinical trials 
conducted primarily in women without diabetes (Mauvais-Jarvis et 
al., 2013; Cagnacci et al., 1992; Davidson et al., 2000; Margolis et 
al., 2004). In particular, the use of E2 has been reported to 
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decrease fasting blood glucose and total cholesterol in diabetic 
postmenopausal women (Crespo et al., 2002).  
Female mitochondria produce less peroxidase than male and have 
higher antioxidant enzymes. So males are more vulnerable to 
mitochondrial damage by oxidative stress (Vina et al., 2003). Since 
estrogen receptors (ER) and its signaling are involved in the 
regulation of antioxidant enzyme expression, female mitochondria 
have a lower ROS and a higher antioxidant defense effect than 
males. For this reason, premenopausal women have less metabolic 
disorders than men with lower E2. ER belongs to the nuclear 
receptor superfamily, which regulates gene expression involved in 
glucose uptake and insulin sensitivity. However, due to the 
reduction in the level of endogenous estrogens, ERα reduction is 
observed in postmenopausal women. Indeed. glucose and energy 
metabolism are dysregulated in female ERα-/- mice (Park et al., 
2011). In addition, ERα knockout mice have found to be 
susceptible to oxidative stress result in induction of induce insulin-
deficient diabetes (Le May et al., 2006). Even if the regulation of 
ERα may play an important role in preventing various 
complications caused by diabetes, it is unclear how E2-induced ER 
regulation in diabetic postmenopausal women controls the 
deleterious consequence of diabetes.  
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B. Antioxidant enzymes   
Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is an 
antioxidant enzyme, which is degraded as Keap1 binds to Nrf2 
under normal conditions. Oxidative stress induces that Nrf2 
translocation into the nucleus. Subsequent translocated Nrf2 binds 
to the antioxidant-related elements and expresses antioxidant 
genes such as MnSOD and catalase, thus cellular protection by ROS 
suppression. However, Nrf2 is degraded by Keap1 glycosylation 
under high glucose conditions, resulting in failure of translocation 
into the nucleus (Rosa et al., 2016). It has been demonstrated that 
Nrf2 expression is reduced in the diabetic/insulin resistance model 
(Essick and Sam, 2010). In addition, oxidative stress levels have 
been reported to increase in Nrf2-deficient diabetic mice (He and 
Ma, 2012, Yoh et al., 2008). Thus, Nrf2 is considered to be an 
essential factor to protect against high glucose-evoked oxidative 
stress and related diseases, but the exact mechanism has not been 
elucidated.  
Sirtuins are a group of seven members of proteins involved in the 
regulation of various biological processes, particularly in longevity, 
metabolism and stress response. Sirt1/2 are located in cytoplasm 
and Sirt3/4/5 are located in mitochondria. Sirt1/6/7 are present in 
the nucleus. Sirtuins in mitochondria regulate the acetylation levels 
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and activity of the antioxidant enzymes to protect mitochondria 
from oxidative stress. In particular, overexpression of Sirt3, a 
nicotinamide adenine dinucleotide (NAD+)-dependent mitochondrial 
deacetylase, has been reported to accumulate mtROS and mitigates 
damage to mitochondria. Excess of ROS can lead to apoptosis 
through membrane lipid and protein oxidation. In addition, Sirt3-
mediated deacetylation activates enzymes that plays in reducing 
ROS in protecting oxidative stress-induced diseases such as 
diabetes and cancer. Indeed, decreased Sirt3 contributes to 
vascular dysfunction in obesity by increasing mtROS and Sirt3-
mediated MnSOD modulates insulin sensitivity (Qiu et al., 2010; Li 
et al., 2004). MnSOD is a major mitochondrial antioxidant enzymes 
and Sirt3 improves antioxidant activity by deacetylation of two key 
lysine residues on MnSOD. In Sirt3 knockout cells, the acetylation 
of MnSOD was significantly increased and the activation of MnSOD 
was decreased (Tao et al., 2010). Additionally, Sirt3 mediated high 
glucose-evoked oxidative stress through MnSOD deacetylation at 
lysine 68 (Guodong et al., 2015). However, the exact mechanism by 
which high glucose-induced oxidative stress reduces the 
antioxidant response elements is not known. Therefore, further 
studies are needed to see how increasing the antioxidant response 
element can lead to prevention of oxidative stress-related diseases. 
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C. Antioxidant effect of E2 
In postmenopausal women, decreased ovarian production reduces 
circulating E2 levels, whereas E2 acts to distant target tissues in 
healthy premenopausal women. This endocrine changes lead to lack 
of glycemic control, which is associated with oxidative stress 
(Monnier and Colette, 2008; Dandona, 2017). E2 is associated with 
antioxidant enzymes expression, which affects circulating redox 
state (Bellanti et al. 2013). E2 acts as a regulator of antioxidant 
gene expression to prevent aging (Hall and Phillips, 2005), diabetes 
(Naziroglu et al., 2004), neurodegenerative disease (Goodman et al., 
1996) and bone loss (Weitzmann and Pacifici, 2006). It has been 
reported that E2 upregulates the nuclear gene expression of 
antioxidant enzymes and interacts with ERs to activate antioxidant 
enzymes through mitogen activated protein kinase (MAPK) and 
nuclear factor kappa B (Borras et al., 2010). Changes in oxidative 
damage and antioxidant enzymes after menopause affect 
physiological changes (Bednarek-Tupikowska et al., 2004; 
Bednarek-Tupikowska et al., 2001). Thus, a decrease in 
endogenous E2 in postmenopausal women may increase the 
incidence of diabetes due to increased oxidative stress (Naziroglu 
et al., 2004), but the exact mechanisms by which E2 signaling are 
activated antioxidative enzymes through oxidative stress regulation 
remain elusive.
  






Regulation of migration in hUCB-MSCs  
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Glucose is an essential nutrient resource for cellular bio-
energetics and components synthesis, such as protein and lipid 
(Saki et al., 2013). Furthermore, glucose is an important regulatory 
element that controls cell fate determination in both physiological 
and pathological conditions (Madonna et al., 2013). Glucose 
metabolism plays a key role in proliferation, self-renewal ability, 
and senescence of stem cells (Ito and Suda, 2014). Previous 
reports investigating the effects of high glucose on stem cell 
functions are controversial as there are differing perspectives. For 
example, some studies have shown that high glucose induces 
senescence and apoptosis in stem cells (Saki et al., 2013; Chang et 
al., 2015; McClelland et al., 2016). Conversely, other studies have 
shown that high glucose stimulates proliferation and enhances 
osteogenic differentiation potential in mesenchymal stem cells 
(MSCs) (Li et al., 2007). These diverse responses to the high 
glucose condition may be relevant for the different glucose 
tolerance of stem cells (Dhanasekaran et al., 2013; Sen et al., 
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2015). Therefore, further investigation into the underlying 
mechanism of high glucose on stem cell functions is needed to 
develop a therapeutic strategy for stem cell therapy. 
The migratory ability of stem cell to injury site is a critical factor 
in determining the therapeutic effect of stem-based therapy. 
Previous reports suggested that enhancing stem cell migration is a 
potential strategy for improving the efficacy of tissue regeneration 
(Horwitz et al., 1999; Sohni and Verfaillie, 2013; De Becker and 
Riet, 2016). Moreover, there have been previous studies showing 
the stimulatory effect of glucose on migration in the various types 
of cells (Takatani-Nakase et al., 2014; Panchatcharam et al., 2010; 
Huang and Sheibani, 2008). However, the effect of glucose on stem 
cell migration is not fully determined. Therefore, identification of a 
key factor regulating migratory mechanism of stem cells under high 
glucose conditions is required to improve therapeutic efficacy of 
stem cell transplantation. Disrupting the cell-cell interaction has 
been considered an essential step for cell migration. Additionally, 
cell detachment is regulated by reducing cell adhesion molecules 
(Vogelmann et al., 2005; Han et al., 2016). Many studies have 
highlighted that detachment is significant during cell migration by 
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which adhesions disassemble (Palecek et al., 1998; Webb et al., 
2002; Kirfel et al., 2004). E-cadherin is a major component of the 
cell adhesion molecules that are formed at cell-cell adherens 
junctions to bind cells via a homophilic mechanism (Takeichi, 1991). 
During dissolution of adherens junctions by the reduced E-cadherin 
expression level, E-cadherin can no longer interact with β–catenin, 
which results in increased cell motility (Zhu et al., 2018). E-
cadherin expression can influence various processes that occur 
during development, organogenesis, tissue formation, and tumor 
progression (Hyafil et al., 1981; Gumbiner, 2005; Takeichi, 1991). 
In particular, E-cadherin expression has emerged as an important 
regulator in cellular movement and invasion (Niewiadomska et al., 
1999; Theveneau and Mayor, 2012; Cai et al., 2014). Furthermore, 
E-cadherin reduction and delocalization accelerated cell migration 
through the Notch signaling which controls the disassembly of cell-
cell adherens junction (Marambaud et al., 2002). However, the 
effect of high glucose on the disruption of E-cadherin-dependent 
cell-cell adherens junction in enhancing cell migration is still 
unknown. 
MSCs are multipotent stem cells, which have differentiation 
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potentials for various kinds of somatic cells, such as osteoblasts, 
adipocytes, chondrocytes, myoblasts, and neural cells (Pittenger et 
al., 1999; Barry and Murphy, 2004). Due to various limitations in 
ESCs and induced pluripotent stem cells (iPSCs) research in 
teratoma formation as well as political and ethical restrictions, 
hUCB-MSCs are considered promising stem cell resources for 
stem cell-based therapies. In addition, previous studies 
demonstrated that the transplantation of hUCB-MSCs accelerates 
the wound healing process by promoting their migratory activity 
(Lee et al., 2016; Ryu and Han, 2015). Thus, I investigated the 
molecular mechanisms underlying the effect of high glucose on 
hUCB-MSC migration and the wound healing effect of high 
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2. MATERIALS AND METHODS 
 
2.1. Materials 
Human UCB-MSCs were kindly provided from the MEDIPOST 
Co., Ltd. (Seoul, Korea) which were isolated and expanded 
according to previous report (Yang et al., 2004). Fetal bovine 
serum (FBS) was purchased from BioWhittaker Inc. (Walkersville, 
MO, USA). Antibodies specific for phospho (p)-JNK (sc-6254), 
JNK (sc-7345), p-ERK (sc-7383), ERK (sc-94), p38 (sc-7149), 
p-GSK-3β (sc-11757), GSK-3β (sc-9168), Snail (sc-28199), 
EZH2 (sc-25383), E-Cadherin (sc-7870), β-actin (sc-47778), 
and Lamin A/C (sc-20681) were purchased from Santa Cruz 
Biotechnology, Inc. (Santa Cruz, CA, USA). Anti-cleaved Notch1 
(4147), Suz12 (3737), Akt (9272), p-p38 (9211) p-AktThr308 
(13038) and p-AktSer473 (4060) antibodies were purchased from 
Cell Signaling Technology, Inc. (Danvers, MA, USA). Antibody 
specific for EED (09-774) was purchased from Millipore 
(Billerica, MA, USA). Secondary antibodies (anti-rabbit; sc-2004, 
anti-mouse; sc-2005, anti-goat; sc-2768) were obtained from 
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Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). D-, L-
Glucose, N-Acetyl-L-cystein (NAC), L-685,458, LY294002, and 
lithium chloride (LiCl) were obtained from Sigma Chemical 
Company (St. Louis, MO, USA). Human Nuclear Antigen (HNA; 
Alexa Fluor 488 antibody) was purchased from Novus Biologicals 
(Littleton, CO, USA). 5-(and-6)-carboxy-2’, 7’-dichloro-
fluorescein diacetate (DCF-DA) was purchased from Molecular 
Probes (Eugene, OR, USA). Akt specific inhibitor was purchased 
from CalBiochem (La Jolla, CA, USA).  
 
2.2. hUCB-MSC culture 
hUCB-MSCs were cultured according to previous report (Jung et 
al., 2015). In this study, passage of hUCB-MSCs from five to eight 
was used and there is no discernible difference between passages 
(Chang et al., 2013). hUCB-MSCs without feeder layer were 
cultured in the α-MEM supplemented with 0.1 mM β–
mercaptoethanol, 1% penicillin and streptomycin, and 10% FBS. 
Cells were grown on gelatinized 100-mm diameter culture dishes at 
37°C with 5% CO2 in the incubator. Cells were transferred to fresh 
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serum-containing α-MEM at least once every two days. Cells, 
cultured at 70-80% confluence, were washed twice with 
phosphate-buffered saline (PBS), and were transferred to serum-
free α-MEM prior to experiments.  
 
2.3. AD-MSC culture 
AD-MSCs without feeder layer were cultured in the α-MEM 
supplemented with 0.1 mM β–mercaptoethanol, 1% penicillin and 
streptomycin, and 10% FBS. Cells were grown on gelatinized 100-
mm diameter culture dishes at 37°C with 5 % CO2 in the incubator. 
Cells were transferred to fresh serum-containing α-MEM at least 
once every two days. Cells were washed twice with PBS, and were 
transferred to serum-free α-MEM prior to experiments.  
 
2.4. Mouse Excisional Wound Splinting Model 
Mouse excisional wound splinting model and hUCB-MSC 
transplantation were performed, as described in the previous 
reports (Wang et al., 2013) and were approved by the Institutional 
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Animal Care and Use Committee (IACUC) at Seoul National 
University (SNU-161128-6). Male ICR mice aged 8 weeks were 
purchased from Han Lim Experimental Animal (Suwon, Korea). 
Mice were acclimated and stabilized in new surroundings for 4 days 
prior to the start of research and collecting data. To investigate the 
functional effects of high glucose-pretreated hUCB-MSC, mice 
were randomly divided into four groups (n = 6 each group): Vehicle, 
high glucose, hUCB-MSCs, and high glucose-pretreated hUCB-
MSCs. To investigate the role of Snail and EZH2 in the migration of 
hUCB-MSC toward wound site, mice were randomly divided into 
six groups (n = 6 each group): non-targeting (NT) siRNA + 
hUCB-MSC, NT siRNA + high glucose-pretreated hUCB-MSC, 
Snail siRNA + hUCB-MSC, Snail siRNA + high glucose-pretreated 
hUCB-MSC, EZH2 siRNA + hUCB-MSC, and EZH2 siRNA + high 
glucose-pretreated hUCB-MSC. Cells were transfected with either 
Snail or EZH2 siRNA for 24 h prior to the high glucose treatment 
for 24 h. Mice were anesthetized with 3% isoflurane in a mixture of 
N2O/O2 gas. Wounds were created by a 6 mm diameter biopsy 
punch (Kai Medical, Seki, Japan) on the back of a mouse, and a 
silicone splinting ring was attached around the wound using medical 
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adhesive with several stitches. 1 × 106 hUCB-MSCs in 100 μL 
saline were transplanted into the dermis at four sites around the 
wounds. Wound dressings were applied using Tegaderm™ (3M, St. 
Paul, MN, USA) to keep out water, dirt and germs. Mice were 
placed in individual cages in controlled rooms (24 ± 2°C, 12/12 h 
light/dark cycle with lights on at 7 AM). All wounds were monitored 
and photographed at different times (days 0, 3, 6, 9, and 11) by 
using a digital camera system (Canon, Tokyo, Japan). Percentages 
of wound size were calculated and analyzed by using Image J 
program. Mice were euthanized for the collection of wound tissue 
samples at day 11. The samples were fixed with 4% 
paraformaldehyde (PFA) in PBS for 4 h. Subsequently, for 
dehydration, the samples were incubated in 20% sucrose in PBS at 
room temperature for 2 h, and then were incubated in 30% sucrose 
at 4°C overnight. The next day, the tissues were embedded in 
O.C.T. compound (Sakura Finetek, Torrance, CA, USA) and were 
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2.5. Haematoxylin and Eosin (H&E) staining 
Wound tissues were cut at thickness of 6 μm using a cryostat 
(Leica Biosystems, Nussloch, Germany) and mounted on 
SuperFrost Plus slides (Thermo Fisher Scientific, Waltham, MA, 
USA). The frozen tissue sections were fixed with 4% PFA for 5 min 
and were washed with running tap water for 5 min. Next, the 
tissues were stained with haematoxylin for 3 min and washed with 
running tap water for 5 min. The slides were placed in acid alcohol 
solution (1% HCl in 70% alcohol) and were stained with eosin 
solution for 30 sec. The slides were repeatedly dehydrated with 
95% and 100% alcohol 3 times, each for 3 sec. Next, the slides 
were placed in xylene for 3 sec and then were mounted on clear 
glass slides. The slides were photographed using Eclipse Ts2-FL 
microscope (Nikon Corporation, Tokyo, Japan). 
 
2.6. Intracellular ROS detection 
Intracellular ROS detection was described in previous reports 
(Song et al., 2016). ROS was detected using DCF-DA, which is a 
fluorescence-based probe for ROS detection. Cells were treated 
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with 10 μM DCF-DA and were wrapped it in foil, due to light 
sensitivity, then placed on shaking incubator for 30 min at room 
temperature. Cells were observed using FluoViewTM 300 confocal 
microscope (Olympus, Tokyo, Japan). To measure the intracellular 
hydrogen peroxide (H2O2) levels, the cells were treated with DCF-
DA and were washed using ice-cold PBS twice. The cells were 
measured by using a luminometer (Victor3; PERKin-Elmer, 
Waltham, MA). 
 
2.7. Oris™ cell migration assay 
hUCB-MSCs were placed at a density of 104 cells/0.1 mL into a 
α-MEM containing serum in Oris™ cell seeding stoppers 
(Platypus Technologies, WI, USA), and were incubated until the 
cells had achieved 90% confluence of monolayers around the cell 
exclusion zone. The cells were transferred to serum-free α-MEM 
prior to experiments, and then silicone stoppers were carefully 
removed after 24 h. The cells were incubated in both with and 
without high glucose and each signal pathway-related molecule 
inhibitors/siRNAs, followed by fixation and staining with 5 μM 
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calcein AM (Wako, Osaka, Japan) in dark for 30 min. Fluorescence 
was measured using a luminometer (Victor3; PERKinElmer Inc., 
Waltham, MA, USA) and a fluorescent plate reader with excitation 
and emission wavelengths at 485 nm and 535 nm, respectively. The 
measurements were shown as Relative Fluorescence Units (RFU).  
 
2.8. Wound-healing migration assay 
hUCB-MSCs were seeded at density of 104 cells/0.1 mL in 35 
mm diameter plates (IBIDI™, Martinsried, Germany) in a medium 
containing serum, and were incubated until the cells had achieved 
90% confluence of monolayers into the inner well of the μ–Dish at 
37°C and 5% CO2 as usual. The old medium was aspirated 
carefully and fresh media was replaced every 2 days. The silicone 
inserts were carefully removed with sterilized forceps after serum-
free treatment for 24 h. The cells were incubated with and without 
high glucose and indicated agents. Cells were pictured by either an 
Olympus FluoViewTM 300 confocal microscope (Olympus, Tokyo, 
Japan) or Eclipse Ts2-FL microscope (Nikon Corporation, Tokyo, 
Japan).  
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2.9. Transfection of small interfering RNA (siRNA) 
hUCB-MSCs that reached 80% confluence were transfected for 
24 h with either a siRNA specific for Snail1, EZH2 or a NT siRNA 
as a negative control (25 nM; Dharmacon, Lafayette, CO, USA) 
using DharmaFECT transfection reagent according to the 
manufacturer’s instructions. The culture medium was replaced 
with transfection mixture- and serum-free medium after 6 h of 
incubation at 37°C and the cells were incubated for 24 h. The 
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2.10. Co-immunoprecipitation (Co-IP) 
hUCB-MSCs were lysed with the co-IP buffer (50 mM Tris-HCl 
[pH 7.4] containing 150 mM NaCl, 5 mM EDTA, 2 mM Na3VO4, 2.5 
mM Na4PO7, 100 mM NaF, 200 nM microcystin lysine‐arginine and 
protease inhibitors) according to the previous report (Ryu et al., 
2015). Cell lysates were added with anti-Snail or EZH2 antibodies 
and Protein A/G PLUS-agarose IP reagent (Pierce; Rockford, IL, 
USA), and then the cell lysates were incubated for 4 h in a shaking 
incubator maintained at 4°C. The beads were washed more than 
three times with the co-IP buffer, and then the bound proteins with 
beads were eluted by boiling for 5 min. Samples were analyzed by 
western blotting with anti-EZH2, EED, Suz12, Snail and histone 
deacetylase 1 (HDAC1) antibodies.  
 
2.11. Cytosol and nuclear fractionation 
hUCB-MSCs were lysed in lysis buffer (20 mM Tris-HCl, 10 
mM EGTA, 2 mM EDTA, 2 mM Dithiothreitol, 1% Triton X-100, 1 
mM phenylmethylsulfonylfluoride [PMSF], 25 mg/mL aprotinin and 
10 mg/mL leupeptin). Lysates were homogenized with lysis buffer 
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and sonicated using a Branson Sonifier 250 (All-spec, Wilmington, 
NC, USA) with set to 4 of output power for 10 sec. The lysates 
were then centrifuged at 8,000 rpm for 5 min at 4°C. The 
supernatant, containing cytosol and membrane, was centrifuged at 
15,000 rpm for 60 min at 4°C, and were divided into cytosol and 
membrane. The pellet, containing the nucleus, was homogenized 
with lysis buffer and sonicated for 10 sec. It was centrifuged at 
15,000 rpm for 15 min at 4°C and the supernatant was collected as 
a nuclear lysate fraction.  
 
2.12. SDS-PAGE and Western blot analysis 
hUCB-MSCs were washed twice with cold-PBS followed by 
incubation on ice. Cells were lysed with lysis buffer (20 mM Tris 
[pH 7.5], 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 1 mg/mL 
aprotinin, 1 mM PMSF, and 0.5 mM sodium orthovanadate) and 
shared with 1 set of 3-second pulses on ice using a Branson 
Sonifier 250 with set to 3 of output power. Sample protein 
separations were resolved by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) and transferred to polyvinylidene 
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difluoride (PVDF) membranes. The membranes were incubated with 
primary antibody (1:800 or 1:1000 dilutions) at 4°C incubator for 
overnight after blocked with TBST (10 mM Tris-HCl [pH 7.6], 150 
mM NaCl, and 0.01% Tween-20) containing 5% skim milk for 1 h. 
Next day, the membranes were washed with PBS and then 
incubated with a HRP secondary antibody. The specific bands were 
detected by ChemiDoc™ XRS+ System (Bio-Rad, Richmond, CA).  
 
2.13. Chromatin Immunoprecipitation assay  
EZ-ChIP-Chromatin Immunoprecipitation Kit (EMD Millipore) 
was used for Chromatin Immunoprecipitation (CHIP) assay. Cells 
were cross-linked by incubation at room temperature with 37% 
formaldehyde for 10 min and added 1 M glycine to quench the 
unreacted formaldehyde according to the manufacturer’s 
instructions. Fixed cells were harvested in SDS lysis buffer (1% 
SDS, 10 mM EDTA, 50 mM Tris [pH 8.1] and protease inhibitors). 
Cell lysates were sonicated, and then were incubated with protein G 
beads (50% protein G agarose slurry) for IP. IP included positive 
control (Anti-RNA polymerase II), negative control (IgG), and 
antibody of interest. The negative control IgG of the same species 
as the antibody of interest was used. Protein/DNA complexes were 
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eluted by incubation at room temperature with elution buffer (20% 
SDS, 1 M NaHCO3 and distilled water) for 15 min. After 
centrifugation, supernatant was collected into new microfuge tubes. 
All IPs and inputs with 5 M NaCl were incubated at 65°C for 
overnight to reverse the protein/DNA cross-links. The purified 
DNA was subjected to PCR and DNA fragments were run on 
agarose gel (2.5%) to facilitate quantitation of the PCR products. 
The sequences of the primers used in the PCR reactions were as 
follows: E-box human promoter (forward primer) 
5’CTCCAGCTTGGGTGAAAGAG 3’, E-box human promoter 
(reverse primer) 5’ GGGCTTTTACAC TTGGCTGA 3’.  
 
2.14. Immunofluorescence staining 
hUCB-MSCs were cultured in confocal dish. Cells were washed 
twice with cold-PBS, and then were fixed with 4% PFA for 10 min 
according to previous report (Jung et al., 2015). 0.1% Triton X-
100 diluted in PBS was used for permeabilization for 5 min. 5% 
Normal Goat Serum (NGS) was used to decrease non-specific 
binding of antibody for 30 min, followed by incubation with primary 
antibody with dilution of 1:100 for overnight. Subsequently, cells 
were incubated with either fluorescein isothiocyanate (FITC) 
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conjugated anti-rabbit and -mouse IgG antibody or Alexa Fluor® 
goat anti-rabbit IgG to either propidium iodide (PI) or phalloidin in 
dark for 1 h. Next, cells were observed using Eclipse Ts2-FL 
microscope (Nikon Corporation, Tokyo, Japan). 
 
2.15. Phalloidin staining 
hUCB-MSCs were cultured in confocal dish. Cells were washed 
twice with cold-PBS, and then were fixed with 4 % PFA for 10 min. 
Subsequently, cells were permeabilized with 0.1 % Triton X-100 in 
PBS for 5 min. After blocking with 1 % FBS or 5 % normal goat 
serum for 30 min, cells were incubated with Alexa Fluor 488-
conjugated to phalloidin (Invitrogen Co., Carlsbad, CA) in dark for 1 
h. Cells were washed twice with PBS. Next, cells were observed 
using Eclipse Ts2-FL microscope (Nikon Corporation, Tokyo, 
Japan). 
 
2.16. Statistical analysis 
Data are represented as mean ± standard error mean (SEM). 
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Statistical analyses were performed using the analysis of variance 
(ANOVA), and Bonferroni-Dunn test allows for multiple 
comparisons in some cases. A p value of < 0.05 was accepted as 
statistical significance. 
  




3.1. Effect of high glucose on migration and effect of 
hUCB-MSCs on mouse skin wound healing 
To confirm the effect of high glucose on hUCB-MSC migration, 
cells were incubated under high glucose conditions for various 
concentrations of D-glucose or L-glucose from 5 to 50 mM and for 
times ranging from 0 to 24 h. D-glucose increased the number of 
migrating cells after cell incubation for 24 h, while L-glucose did 
not have an effect on the cells (Figure 5A), suggesting that the 
osmotic effect did not influence high glucose on hUCB-MSC 
migration. I also quantified the percent migration by using the 
Oris™ cell migration assay and observed a maximum increase of up 
to 151% after incubating cells with 25 mM D-glucose for 24 h 
(Figure 5B). High glucose also facilitated hUCB-MSC migration to 
the detection zone (Figure 5C). In order to distinguish cell 
migration from proliferation, cells were pretreated with Mitomycin 
C to inhibit cell proliferation. As a result, I observed no significant 
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differences between the groups treated with or without Mitomycin 
C under high glucose conditions. This means that high glucose-
induced hUCB-MSC proliferation did not affect hUCB-MSC 
migration (Figure 5D). As shown in Figure 6, high glucose induced 
F-actin cytoskeleton reorganization, and formed cell-motility 
structures at the leading edges of the cells. The cytoskeleton 
changes occurred at various time periods by high glucose in hUCB-
MSCs. In addition, other sources of MSCs, Adipose-derived 
mesenchymal stem cells (AD-MSCs), significantly stimulated the 
migration after incubating cells with 25 mM glucose for 24 h 
(Figure 7). In order to investigate the wound healing effect of high 
glucose-pretreated hUCB-MSCs, I used a mouse skin excisional 
wound splinting model and performed wound size measurements, 
histological examinations, and blood vessel density measurements. 
The wound area of the high glucose-pretreated hUCB-MSC group 
compared to that of the hUCB-MSC alone was significantly reduced 
at 11 days after wounding as well as the wound area of hUCB-MSC 
transplanted groups compared to basal conditions (Figure 8A and 
8B). Histological examination of wound tissues on day 11 showed 
that the wound site was completely filled with granulation tissues 
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by high glucose pretreated hUCB-MSCs transplantation compared 
to the wounds of vehicle, high glucose, or hUCB-MSC group 
(Figure 8C). To track transplanted hUCB-MSCs in vivo on day 11, 
wound tissues were stained with anti-human nuclear antigen 
(HNA) antibody. Immunohistochemistry revealed many HNA-
positive cells in high glucose-pretreated hUCB-MSC group, 
whereas in vehicle or high glucose group, no HNA-positive cells 
were found (Figure 9A). Blood vessels that developed many 
branches were observed in hUCB-MSC transplanted groups 
compared to the vehicle or high glucose treated group (Figure 9B). 
Collectively, the data suggest that hUCB-MSCs cultured with high 
glucose significantly increased migratory activity compared to those 
cultured at a normal physiological glucose level. Moreover, high 
glucose-pretreated hUCB-MSC transplantation significantly 
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Figure 5. Effect of high glucose on hUCB-MSC migration. Dose 
response effects of D-glucose (5-50 mM) or L-glucose (5-50 
mM) for 24 h, and (B) time (0-24 h) response effects of high 
glucose (D-glucose, 25 mM) or normal physiological conditions of 
glucose (5 mM) on hUCB-MSC migration were measured with 
Oris™ cell migration assay. hUCB-MSCs cultured with normal 
medium were regarded as the control. n = 3. *p < 0.05 versus 5 mM 
D-glucose. (C) Wound healing migration assay was performed in 
the presence of high glucose (25 mM) and with the IBIDI™ cell 
culture inserts. Cells were treated with 25 mM glucose for various 
time periods (0-24 h). Wound width = 500 μm. Scale bars = 100 
μm. (D) Cells were pretreated with 1 μg/mL mitomycin C for 90 
min prior to 25 mM glucose treatment for 24 h. Fluorescence in the 














Figure 6. Effect of high glucose on F-actin reorganization of hUCB-
MSCs. hUCB-MSCs were treated with 25 mM glucose for various 
periods (0–24 h). F-actin was stained with phalloidin staining 
(green) and counterstained with PI (red). Cells were observed with 








Figure 7. Effect of high glucose on AD-MSC migration. (A) AD-
MSCs were incubated with 25 mM glucose for 24 h and migration 
were measured by Oris™ migration assay. Fluorescence in the 
analytical zone was quantified with a multiplate reader. n=3. *p < 
0.05 versus ctrl. (B) Wound healing migration assay was performed. 
Cells were stained with Alexa Fluor 488-phalloidin and PI and the 
dishes were photographed using Eclipse Ts2-FL microscopy 
(Nikon Corporation, Tokyo, Japan). Scale bar = 100 μm. 
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Figure 8. Effect of high glucose-pretreated hUCB-MSC 
transplantation in mouse skin wound healing. (A) Representative 
gross images of wounds at days 0, 3, 6, 9, and 11 are shown. (B) 
Wound sizes were measured using ImageJ software. n=6 each 
group. *p < 0.05 versus vehicle + hUCB-MSC group. #p < 0.05 
versus vehicle group. $p < 0.05 versus high glucose group. (C) 
Wound tissues were stained by using H&E staining at day 11 after 
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Figure 9. Effect of high glucose-pretreated hUCB-MSC 
transplantation on cell survival and angiogenesis. (A) Wound tissues 
were immunostained with human nuclear antigen (HNA; green) and 
PI (red). Scale bar = 50 μm. (B) Representative gross images of 
blood vessels in wound site at day 11 are shown (left panel). Blood 
vessel density was analyzed by optical density using ImageJ 
software (right panel). *p < 0.05 versus vehicle group, #p < 0.05 
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3.2. Effect of high glucose on E-cadherin, cleaved 
Notch, Snail and EZH2 expression 
Because regulation of E-cadherin expression plays an important 
role in cell migration, I investigated the effect of high glucose-
induced E-cadherin repression in hUCB-MSCs. Human UCB-
MSCs were incubated at high glucose conditions for up to 48 h to 
verify E-cadherin expression and to examine whether high glucose 
affected E-cadherin, which is related with hUCB-MSC migration. 
E-cadherin expression decreased gradually after 12 h incubation 
under high glucose conditions (Figure 10A). In addition, cleaved-
Notch, Snail and EZH2 expressions were increased in a time-
dependent manner under high glucose conditions (Figure 10B). To 
confirm the role of high glucose-induced E-cadherin by regulating 
Snail and EZH2 expressions, NT, Snail, and EZH2 siRNA 
transfections were carried out. The levels of E-cadherin were 
reduced by NT siRNA while Snail and EZH2 siRNA restored the E-
cadherin level under high glucose conditions (Figure 11A). To 
confirm the signaling relationship between Snail and EZH2, Snail 
and EZH2 siRNA transfections were carried out. Interestingly, the 
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protein levels of Snail were not reduced by EZH2 siRNA, and the 
levels of EZH2 were not reduced by Snail siRNA (Figure 11B). 
Hence, these results indicate that high glucose-induced E-cadherin 
repression is regulated by Snail and EZH2, and Snail is regulated in 











Figure 10. Effect of high glucose on E-cadherin, Notch, Snail and 
EZH2 expression. (A) Expression of E-cadherin was analyzed by 
western blot with a specific antibody. Cells were exposed to high 
glucose for 0 to 48 h, and the total lysates were analyzed by 
western blot with anti-E-cadherin antibody. β–actin was used as a 
loading control. n=3. *p < 0.05 versus 0 h. (B) hUCB-MSCs were 
incubated under high glucose conditions for 0 to 48 h, and the total 
cell lysates were analyzed by western blot with antibodies that 
recognize cleaved-Notch, Snail and EZH2. β–actin was used as a 
loading control. n=3. *p < 0.05 versus 0 h. 
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Figure 11. Effect of high glucose on E-cadherin, through Snail and 
EZH2 signaling in hUCB-MSCs. (A) Cells were treated with NT-, 
Snail- or EZH2 siRNA in presence or absence of 25 mM glucose. 
E-cadherin was analyzed by western blot. n=3. *p < 0.05 versus 
NT siRNA only and #p < 0.05 versus high glucose with NT siRNA 
transfection. (B) hUCB-MSCs were left untransfected or 
transfected with NT siRNA or specific siRNA that silences EZH2 or 
Snail expression and then treated for a further 24 h with 25 mM 
glucose. n=3. *p < 0.05 versus NT siRNA only. NS = non-
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3.3. Role of ROS-stimulated JNK/Notch and 
PI3K/Akt/GSK-3β pathways in high glucose-
induced EZH2 and Snail expressions 
High glucose stimulation is well known to increase the ROS 
production. To examine the effect of high glucose on ROS 
generation in hUCB-MSCs, high glucose-induced ROS generation 
was examined using DCF-DA, to gradually increase ROS generation 
(Figure 12). The activation of MAPK and Akt pathways play 
important roles in migration induction under high glucose conditions 
(Huang and Sheibani, 2008; Lee and Han, 2010). Thus, I further 
investigated whether high glucose-induced ROS can modulate the 
MAPK regulation. High glucose significantly enhanced the JNK 
activation at 180 min while phosphorylation levels of ERK and p38 
MAPK had no time-related changes (Figure 13). Blockage of ROS 
in hUCB-MSCs under high glucose conditions led to decreased JNK 
activation compared to high glucose alone. However, ROS inhibition 
with NAC treatment did not lead to the inhibition of phosphorylation 
of ERK and p38 MAPK (Figure 14A). Furthermore, high glucose-
induced hUCB-MSC migration was blocked by NAC or SP600125 
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(Figure 14B). In order to investigate whether ROS-induced p-JNK 
in high glucose conditions regulates γ-secretase in hUCB-MSCs, 
I performed western blotting after isolating the nuclear fraction. In 
the nucleus, cleaved-Notch was down-regulated after treating 
hUCB-MSCs with SP600125. However, pretreatment with 
PD98059 and SB203580 did not impact the cleaved-Notch as well 
as the degradation of cleaved-Notch after SP600126 treatment in 
high glucose conditions in the nucleus (Figure 15A). Furthermore, 
high glucose elevated the expression of EZH2, which was 
suppressed by the L-685,458 (Figure 15B). These results show 
that ROS-mediated JNK activation regulated γ-secretase-
induced Notch cleavage for Notch intracellular domain (NICD) 
under high glucose conditions.  
To assess whether high glucose-induced ROS production can 
regulate PI3K/Akt and GSK-3β signaling pathways, I measured 
the total expression and activation of Akt and GSK-3β. Aktthr308 
and Aktser473 phosphorylation were gradually increased by 
incubation in high glucose conditions (Figure 16A). In addition, NAC 
blocked high glucose-induced Aktthr308 and Aktser473 phosphorylation, 
which suggest that high glucose-induced activation of Akt at thr308 
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and ser473 was regulated by ROS (Figure 16B). I next investigated 
whether PI3K/Akt signaling induced phosphorylation of GSK-3β. 
In high glucose conditions, the inhibitions of PI3K/Akt with 
LY294002 or the Akt inhibitor blocked GSK-3β phosphorylation 
(Figure 16C), resulting in subsequent Snail stabilization. As shown 
in the details of Figure 16D, although the total expression levels of 
GSK-3β were unmodified by high glucose, the level of GSK-3β 
phosphorylation increased in a time-dependent manner. In order to 
determine whether high glucose increased Snail expression through 
GSK-3β phosphorylation, the cells were pretreated with LiCl, a 
well-known GSK-3β inhibitor. LiCl increased the inactive 
phosphorylated form of GSK-3β at ser9 and Snail expression 
(Figure 16E). These results suggest that high glucose-induced ROS 
regulates the activation of PI3K/Akt signaling to inhibit GSK-3β. 












Figure 12. Role of high glucose on ROS generation. The cells were 
incubated in high glucose conditions for 0-60 min. 
Dichlorofluorescein-sensitive cellular ROS was detected by 











Figure 13. Time-dependent activation of MAPK by high glucose. 
Cells were incubated under high glucose for 0-180 min, and the 
total lysates were analyzed by western blot with antibodies that 
recognize MAPK proteins. n=3. *p < 0.05 versus 0 min.   
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Figure 14. Role of ROS-dependent JNK signaling pathway. (A) NAC 
(ROS inhibitor; 10 μM) was used for pretreatment prior to 
incubation in the high glucose conditions. p-JNK, p-ERK or p-p38 
was analyzed by western blot. n=3. *p < 0.05 versus ctrl of p-JNK. 
#p < 0.05 versus high glucose alone of p-JNK. (B) Wound healing 
migration assay was performed in the pretreatment of NAC or 
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Figure 15. Role of ROS-dependent Notch signaling pathway under 
high glucose conditions. (A) hUCB-MSCs were pretreated with 
SP600125 (JNK inhibitor; 1 μM), PD98059 (ERK inhibitor, 10 
μM), or SB203580 (p38 MAPK inhibitor, 1 μM) for 30 min before 
incubation under high glucose conditions, and then, the nuclear 
fractions were isolated from cells as describe in the “Materials and 
Methods”. Lamin A/C was used as a nuclear marker. n=3. *p < 
0.05 versus ctrl. #p < 0.05 versus high glucose alone. (B) L-
685,458 (γ-secretase inhibitor; 10 μM) was used for 
pretreatment prior to incubation under high glucose conditions for 
24 h. Cleaved-Notch and EZH2 were detected by western blot. 
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Figure 16. Role of ROS-dependent PI3K/Akt/GSK-3β signaling 
pathway. (A) hUCB-MSCs were incubated under high glucose 
conditions for 0-180 min, and the total cell lysates were analyzed 
by western blot with antibodies the recognize p-AktThe308, p-
AktSer473, or Akt. n=3. *p < 0.05 versus 0 min. (B) The cells were 
pretreated with NAC prior to incubation under high glucose 
conditions for 180 min. p-AktThe308, p-AktSer473, or Akt was 
analyzed by western blotting. n=3. *p < 0.05 versus ctrl, #p < 0.05 
versus high glucose alone. (C) The cells were pretreated with 
LY294002 (PI3K inhibitor; 1 μM), or Akt inhibitor (10 μM) prior 
to incubation under high glucose conditions, and p-GSK-3β and 
GSK-3β were detected. n=3. *p < 0.05 versus ctrl, #p < 0.05 
versus high glucose alone. (D) Cells were incubated under high 
glucose conditions for 0-180 min, and p-GSK-3β or GSK-3β 
was detected. n=3. *p < 0.05 versus 0 min. (E) Cells were treated 
with LiCl (10 mM) for 30 min. The total cell lysates were analyzed 
by western blot using antibodies that recognized p-GSK-3β, 
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3.4. Effect of high glucose on the formation of 
EZH2/Snail /HDAC1 complex in the nucleus 
Next, I examined the role of high glucose-induced Snail and 
EZH2 accumulation in the nucleus. To determine the cellular 
fraction where cleaved-Notch, Snail, and EZH2 accumulated, I 
tested the nuclear and cytosolic fraction before performing a 
western blot analysis. High glucose enriched cleaved-Notch, Snail, 
and EZH2 in the nuclear fraction. While the cytoplasmic levels of 
cleaved-Notch did not change, the cytoplasmic levels of Snail and 
EZH2 increased (Figure 17A). Immunofluorescence staining 
indicated that Snail or EZH2 present in the cytoplasm accumulated 
around the nucleus and translocated to the nucleus under high 
glucose conditions (Figure 17B and 17C). To examine whether 
Snail and EZH2 are required for binding to the E-box of the E-
cadherin promoter under high glucose conditions, I performed CHIP 
to analyze whether Snail and EZH2 were recruited to the E-
cadherin promoter. The CHIP assays revealed that high glucose 
enhanced the interaction between Snail and the E-cadherin 
promoter. In addition, the interaction between EZH2 and the E-
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cadherin promoter was also enhanced by high glucose (Figure 18A). 
To determine the effect of high glucose on PRC2 complex formation, 
I evaluated the effect of high glucose on co-IP of EZH2 and Suz12, 
or EZH2 and EED. Suz12 or EED were co-immunoprecipitated with 
EZH2 by high glucose in the nucleus (Figure 18B). In addition, Snail 
was also able to associate with the PRC2 complex by high glucose 
(Figure 18C). Subsequently, to examine the relationship between 
Snail and PRC2 by high glucose, hUCB-MSCs were transfected 
with Snail siRNA prior to incubation for 24 h in high glucose 
conditions. In the nucleus, high glucose enhanced the EZH2 and 
Suz12, or EZH2 and EED complex. However, Snail siRNA disrupted 
the interaction between EZH2 and Suz12, or EZH2 and EED (Figure 
19A), suggesting that Snail is required to bind the complexes and 
has important functions in hUCB-MSC migration. Interestingly, it 
has been reported that Snail is associated with the PRC2 complex 
for the repression of E-cadherin by the recruitment of HDAC, so 
the Snail was checked to see if it controlled the action of HDAC. As 
shown in Figure 19B, binding HDAC1 with the major component of 
PRC2, EZH2, was increased under high glucose conditions, whereas 
Snail-knockdown hUCB-MSCs maintained the interaction between 
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EZH2 and HDAC1. This suggests that the presence of HDAC1 is 
necessary to associate the Snail and PRC2 complex. These results 
demonstrate that Snail interacts with PRC2 by high glucose in the 
nucleus, and the complex binds with E-box of the E-cadherin 
promoter, which in turn causes the E-cadherin repression. 
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Figure 17. Effect of high glucose on nuclear translocation of Snail and 
EZH2. (A) Cells were incubated under high glucose conditions for 
24 h, and the lysate were fractionized into the cytosol and nuclear 
parts. The fractions were subjected to SDS-PAGE, and expression 
levels of cleaved-Notch, Snail and EZH2 were detected. Lamin A/C 
was used as a nuclear marker and β–actin was used as a cytosolic 
marker, respectively. n=3. (B, C) Cells were stained with Snail and 
EZH2 antibody and counterstained with PI. Fluorescence density of 
Snail and EZH2 in the cellular region was confirmed by 
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Figure 18. Effect of high glucose on PRC2 complex formation. (A) 
hUCB-MSCs were cross-linked with formaldehyde directly in 
the culture medium after treatment with high glucose for 24 h. 
DNA was sheared and immunoprecipitated with an anti-Snail and 
anti-EZH2 antibody. After reversing the cross-linking, the DNA 
was amplified using the E-cadherin primer, CDH-1. (B) 
Immunoassay of nuclear extracts of hUCB-MSCs was left 
untreated or incubated with high glucose, assessed by IP with 
anti-EZH2 (IP: EZH2) or without IP (lysate), followed by IB 
analysis (IB: Suz12 and EED). Lamin A/C was used as a nuclear 
marker. n=3. *p < 0.05 versus ctrl. (C) Immunoassay of nuclear 
extracts of hUCB-MSCs was left untreated or incubated with high 
glucose, assessed by IP with anti-Snail (IP: Snail) or without IP 
(lysate), followed by IB analysis (IB: PRC2 components). Lamin 
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Figure 19. Relationship between Snail and PRC2 by high glucose in 
nucleus. (A) Immunoassay of nuclear extracts of hUCB-MSCs 
was left transfected with NT siRNA or specific siRNA that silence 
Snail expression and then was treated for 24 h with 25 mM 
glucose, assessed by IP with anti-EZH2 or without IP (lysate), 
followed by IB (PRC2 components). n=3. *p < 0.05 versus NT 
siRNA only. #p < 0.05 versus high glucose with NT siRNA 
transfection. (B) Immunoassay of nuclear extracts of hUCB-
MSCs was left transfected with NT siRNA or specific siRNA that 
silence Snail expression and then treated for a further 24 h with 
25 mM glucose, assessed by IP with anti-EZH2 or without IP 
(lysate), followed by IB (HDAC1). n=3. *p < 0.05 versus NT 
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3.5. Role of high glucose-induced Snail and EZH2 in 
E-cadherin expression, migration and mouse skin 
wound healing efficacy  
To examine the role of high glucose and its related signal 
molecules on hUCB-MSC migration, I pretreated the cells with NAC, 
SP600125, L-685,458, and LY294002 prior to high glucose 
treatment in normal hUCB-MSC culture conditions. Pretreatment 
with NAC, SP600125, L-685,458, or LY294002 restored the E-
cadherin expression level that has been reduced by high glucose 
(Figure 20A). The Oris™ cell migration assay was used to quantify 
the amount of migration. Consequently, high glucose-induced cell 
migration was inhibited by each signal pathway-related molecule 
inhibitor or siRNAs (Figure 20B). The effects of high glucose were 
confirmed with the IBIDI™ culture insert dish assays (Figure 20C). 
Furthermore, to evaluate the function of E-cadherin, transfection of 
E-cadherin siRNA was performed. Silencing E-cadherin enhanced 
hUCB-MSC migration, so E-cadherin affects the migration ability 
in hUCB-MSCs (Figure 21A and 21B). To examine the relationship 
between Snail/EZH2 expression and skin wound healing effect of 
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high glucose-pretreated hUCB-MSCs, I performed hUCB-MSC 
transplantation transfected with Snail or EZH2 siRNA into the 
wound sites in mice. The wounds of high glucose-pretreated EZH2 
siRNA + hUCB-MSC group remained unrepaired as well as the 
structures of the epidermis and dermis, compared to the wounds of 
high glucose-pretreated NT siRNA + hUCB-MSC group (Figure 
22A and 22B). HNA-positive cells in the high glucose-pretreated 
EZH2 siRNA + hUCB-MSC group were not found much when 
compared to the high glucose-pretreated NT siRNA + hUCB-
MSCs group (Figure 22C). In addition, the wound area of Snail 
siRNA-treated hUCB-MSC group compared to the wounds of high 
glucose-pretreated NT siRNA + hUCB-MSC group did not heal 11 
days after wounding (Figure 23A). The histological examination of 
wound tissues observed that the wound site was completely filled 
with granulation tissues in high glucose-pretreated NT siRNA + 
hUCB-MSCs group as opposed to the wounds of NT siRNA treated 
hUCB-MSC, Snail siRNA-treated hUCB-MSC, or the high 
glucose-pretreated Snail siRNA + hUCB-MSC group (Figure 23B). 
Immunohistochemistry revealed that there were many HNA-
positive cells in the high glucose-pretreated NT siRNA + hUCB-
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MSC group, whereas the wound tissues in NT siRNA treated 
hUCB-MSC, Snail siRNA-treated hUCB-MSC, or high glucose-
pretreated Snail siRNA + UCB-MSC group contained much less 
HNA-positive cells (Figure 23C). Thus, these results indicate that 
high glucose-preactivated hUCB-MSC transplantation accelerates 
skin wound closure.  
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Figure 20. Role of high glucose on E-cadherin repression and 
hUCB-MSC migration. (A) Cells were incubated in 5 mM glucose 
(ctrl), 25 mM glucose (HG) and 25 mM glucose with either NAC, 
SP600125, L-685,458, LY294002 or LiCl for 24 h, and E-
cadherin was analyzed by western blot. n=3. *p < 0.05 versus 
ctrl; #p < 0.05 versus high glucose alone. (B) OrisTM migration 
assay was performed with cells pretreated with L-685,458, 
LY294002, LiCl, EZH2-, and Snail-specific siRNA prior to 
treatment of high glucose for 24 h. Fluorescence in the analytical 
zone was quantified with a plate reader. n=3. *p < 0.05 versus 
ctrl; #p < 0.05 versus high glucose alone. (C) Wound healing 
assay was performed with the pretreatment of L-685,458, 
LY294002, LiCl, EZH2-, Snail-, EZH2-specific siRNA, and NT 
siRNA in the presence/absence of high glucose. Scale bars = 200 
μm. 
  




Figure 21. Role of E-cadherin in high glucose-induced migration 
of hUCB-MSCs. (A) Cells were incubated in 25 mM glucose for 
24 h and migration were measured by OrisTM migration assay. 
Fluorescence in the analytical zone was quantified with a plate 
reader. n=3. *p < 0.05 versus NT siRNA. (B) IBIDITM wound 
healing migration assay was performed. Cells were stained with 
Alexa Fluor 488-phalloidin and PI and the dishes were 
photographed using Eclipse Ts2-FL microscopy (Nikon 
Corporation, Tokyo, Japan). Scale bars = 100 μm. 
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Figure 22. Role of EZH2 on enhancing the therapeutic efficacy in 
repairing skin wound. (A) Representative gross images of wounds 
at days 0, 3, 6, 9, and 11 are shown (left panel). Wound sizes 
were measured using ImageJ software (right panel). n=6 each 
group. *p < 0.05 versus NT siRNA + Vehicle + hUCB-MSCs 
group. (B) Wound tissues were stained by using H&E staining at 
day 11 after wounding. Scale bar = 200 μm or 100 μm. (C) 
Wound tissues were immunostained with HNA (green) and PI 
(red). Scale bar = 50 μm. 
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Figure 23. Role of Snail on enhancing the therapeutic efficacy in 
repairing skin wound. (A) Representative gross images of wounds 
at days 0, 3, 6, 9, and 11 are shown (left panel). Wound sizes 
were measured using ImageJ software (right panel). n=6 each 
group. *p < 0.05 versus NT siRNA + vehicle + hUCB-MSCs 
group. (B) Wound tissues were stained by using H&E staining at 
day 11 after wounding. Scale bar = 200 μm or 100 μm. (C) 
Wound tissues were immunostained with HNA (green) and PI 















In this study, I showed the effect of high glucose on enhancing the 
migration of hUCB-MSC and the involvement of Notch signaling 
pathway, which contributes to E-cadherin repression through the 
interplay between Snail and EZH2. According to previous reports 
investigating cell migration under high glucose condition, the effect 
of glucose on cell migration still remains controversial depending on 
the cell types (Takatani-Nakase et al., 2014; Suzuki et al., 1996; 
Farnoodian et al., 2016). My data in this study revealed that high 
glucose stimulates hUCB-MSC migration with suppression of E-
cadherin expression (Figure 24). Moreover, I presented in vivo 
proof showing that high glucose-pretreated hUCB-MSCs promoted 
the migration of transplanted cells into the wound site and 
accelerated the skin wound closure in a mouse excisional wound 
splinting model. Previous reports demonstrated that the 
augmentation of MSC migration to the wound site increases the 
efficacy of wound healing through beneficial effects (Jung et al., 
2015; Rosova et al., 2008; Oh et al., 2015; Chen et al., 2012). Thus, 
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migration is considered to be an important factor of MSC-induced 
wound healing. E-cadherin degradation by netrin pretreatment 
enhances migratory ability of hUCB-MSCs (Lee et al., 2014). The 
reduction of E-cadherin expression during cell migration can be 
controlled by epigenetic transcriptional regulation and post-
transcriptional modification of transcription for the CDH1 gene 
(Serrano-Gomez et al., 2016). My results investigating the effect 
of high glucose on E-cadherin and its epigenetic regulators showed 
that high glucose decreased the expression of E-cadherin via 
increasing the expressions of EZH2 and Snail. Epigenetic factors 
have key roles in modulating E-cadherin expression, and the 
epigenetic silencing of E-cadherin is mediated by histone-
modifying enzymes including Snail1 and EZH2 (Herranz et al., 
2008; Di Croce and Helin, 2013). Based upon these findings, I 
suggest that epigenetic regulation of E-cadherin is a critical factor 
for high glucose-stimulated migration in hUCB-MSCs. 
Extracellular glucose influences ROS formation as mediators of 
intracellular signaling cascades (Ha and Lee, 2000; Schroder, 2014). 
ROS acts as an intracellular messenger inducing a variety of 
intracellular events such as protein phosphorylation and gene 
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expression (Chess et al., 2005; Lee et al., 2004, Sauer et al., 2001). 
Indeed, my results showed high glucose stimulated intracellular 
ROS production, and JNK phosphorylation was induced by high 
glucose-induced ROS. Similarly, it was reported that the motility of 
MSCs was promoted by ROS-induced MAPK phosphorylation under 
shear stress conditions while high glucose-induced ROS 
distinctively phosphorylated JNK in renal mesangial cells (Zhang et 
al., 2012). This observation may indicate that JNK activation is 
more responsive to high glucose treatment than ERK and p38 
MAPK via high glucose-induced ROS dependent manner in hUCB-
MSCs. Furthermore, I also showed that JNK phosphorylation 
stimulates γ–secretase-dependent Notch cleavage, leading to 
translocation of NICD into the nucleus. Previous reports 
demonstrated that JNK contributes to γ–secretase activation, but 
ERK1/2 acts as a negative regulator of γ–secretase activity (Shen 
et al., 2008; Kim et al., 2006). These findings support my results 
that high glucose-induced p-JNK could trigger Notch signaling via 
γ–secretase activation. In addition, it was reported that high EZH2 
expression is associated with increased Notch1 activation (Gonzalez 
et al., 2014). Furthermore, my data showed that pretreatment of 
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γ-secretase inhibitor suppressed the high glucose-induced 
cleaved Notch and EZH2 expressions. Therefore, previous and 
present findings indicate Notch signaling activated by JNK could be 
involved in high glucose-induced EZH2 expression. 
Considering the regulatory mechanism of Snail by high glucose, 
previous reports demonstrated that the stabilization of Snail was 
regulated by the Akt/GSK-3β pathway (Guo et al., 2014; Wang et 
al., 2013). Previous study revealed high glucose-induced 
ROS/PI3K/Akt pathway involving in functional regulation of stem 
cells (Kim et al., 2006). Although previous research reported high 
glucose-activated GSK-3β plays an inhibitory role in proliferation 
and migration of bone marrow-derived MSCs (Zhang et al., 2016), 
present data revealed that high glucose-induced ROS 
phosphorylates Akt, which subsequently induced Snail expression 
via GSK-3β inhibition in hUCB-MSCs. Consistent with my results, 
GSK-3β activation can maintain epithelial morphology by 
proteosomal degradation of Snail, thereby maintaining high E-
cadherin expression (Nieto, 2002; Lunyak and Rosenfeld, 2008). 
Thus, I suggest that the Akt/GSK-3β pathway activated by high 
glucose is a major pathway upregulating Snail expression in hUCB-
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MSCs. 
Previous reports have shown that epigenetic regulation is an 
important factor in the regulation of stem cell fate (Lunyak and 
Rosenfeld, 2008; Wang et al., 2017). EZH2 has been considered an 
essential factor for epigenetic regulation of E-cadherin (Herranz et 
al., 2008). Binding of PRC2 members, such as EZH2, Suz12, and 
EED, to the promoter of target gene induces epigenetic regulation 
that is regulated by Snail, which cooperates with PRC2 (Herranz et 
al., 2008; Di Croce and Helin, 2013; Simon and Kingston, 2013; 
Tong et al., 2012). Snail is also required for EZH2-mediated E-
cadherin repression and the complex of EZH2/HDAC/Snail 
contributed to E-cadherin silencing in carcinomas (Tong et al., 
2012; Peinado et al., 2004). In this study, high glucose stimulated 
Suz12/EED/EZH2 complex formation for E-cadherin inhibition, 
which was regulated by the high glucose-stabilized Snail. In 
addition, several studies reported that Snail interacts with the 
HDAC to repress E-cadherin (Peinado et al., 2004; von Burstin et 
al., 2009). HDACs are enzymes that play crucial roles in the 
deacetylation of chromatin proteins and in the regulation of non-
histone proteins for cellular homeostasis (Munshi et al., 2005). As 
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intermediaries between Snail and PRC2, HDAC promotes PRC2 
which links with Snail at the promoter region of E-cadherin (Lin et 
al., 2014). Additionally, an overexpression of Snail stimulates 
recruitment of the HDAC1/HDAC2 complex, which leads to 
deacetylation of histone H3 and H4 at the CDH1 promoter (Peinado 
et al., 2004). Indeed, my data showed that Snail induced by high 
glucose increases the interaction of HDAC1 with EZH2. This finding 
presents the possibility that high glucose-induced Snail regulates 
PRC2 activity to repress E-cadherin expression via HDAC1. My 
data confirmed the regulatory effect of EZH2 and Snail regulated by 
JNK/Notch and Akt/GSK-3β pathways on high glucose-induced 
E-cadherin repression and migration of hUCB-MSCs. Furthermore, 
my skin wound healing results showed that silencing EZH2 or Snail 
suppressed the wound healing effect of hUCB-MSCs and decreased 
the migration of transplanted cells into the wound sites. These data 
indicate that both EZH2 and Snail are critical factors in determining 
the therapeutic efficacy of high glucose-pretreated hUCB-MSCs. 
However, further investigations into the role of high glucose-
induced epigenetic regulation of E-cadherin in other physiological 
functions of hUCB-MSC are needed to understand the therapeutic 
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Figure 24. The hypothetical model for the proposed signaling 
network was involving in high glucose-induced hUCB-MSC 
migration. High glucose enhances ROS, which activates either JNK 
or PI3K/Akt signaling. High glucose-induced JNK activation 
stimulated γ–secretase, and elicits the cleavage of the Notch 
protein. NICD induced the EZH2 expression, and allows them to 
translocate to the nucleus. Stimulation of high glucose leads to an 
induction of phosphorylation of GSK-3β via the PI3K/Akt pathway, 
which leads to Snail stabilization. Once in the nucleus, EZH2 makes 
a complex with Suz12 and EED, and the complex associates with 
the E-box of the promoter regions of E-cadherin by Snail. These 
complexes have an inductive effect on hUCB-MSC migration by the 
repression of E-cadherin. NAC: ROS inhibitor; SP600125: JNK 
inhibitor; L-685,458: γ-secretase inhibitor; LY294002: PI3K 
inhibitor; LiCl: GSK-3β inhibitor. Abbreviations: ROS, reactive 
oxygen species; JNK, c-Jun N-terminal kinases; PI3K, 
phosphoinositide 3 kinase; Akt, protein kinase B; NICD, Notch 
intracellular domains; EZH2, enhancer of zeste homolog 2; GSK-
3β, glycogen synthase kinase 3 beta; Suz2, suppressor of zeste 12; 
EED, embryonic ectoderm development; NAC, N-acetyl-L-
cysteine; LiCl, lithium chloride.  
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1. INTRODUCTION 
Hyperglycemia plays a role in the pathogenesis of diabetic 
complications by enhancing oxidative production and impairing the 
antioxidant defense (Vincent et al., 2004). High glucose enhances 
NADPH-oxidase activation and subsequently induces ROS 
production in the mitochondria. Excessive ROS generation by high 
glucose depletes antioxidant defenses, making cells and tissues 
more vulnerable to oxidative stress, and eventually changing the 
cellular functions (Matough et al., 2012). Thus, the loss of efficacy 
with increased ROS and altered cellular physiology occur in diabetic 
patients even if many researchers have attempted to use 
therapeutic applications like stem cell therapy. This unbalanced 
oxidative mechanism ultimately increases the promoted cell death, 
including apoptotic and necrotic mechanisms. Interestingly, there 
have been several recent reports suggesting that high glucose-
induced oxidative stress causes cell death that can lead to 
decreased therapeutic efficacy of stem cells (Gu et al., 2016). 
However, the mechanisms of how high glucose regulates autophagic 
cell death through ROS regulation are not fully understood. 
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Postmenopausal women tend to be in hyperglycemic states and 
associated with a higher risk of diabetes since E2 is a significant 
regulator of energy homeostasis and glucose metabolism (Crespo et 
al., 2002). E2 also plays an important role in regulating antioxidant 
enzyme expression and redox state (Bellanti et al., 2013). Thus, 
the protective mechanisms of E2 on preventing excessive ROS 
production under hyperglycemia must be investigated as they 
represent the state of diabetic patients. E2 signaling is mediated 
through the ERs that belongs to the nuclear superfamily: ERα and 
ERβ. Among ERs, ERα has been reported to have more nuclear 
transcriptional activity than ERβ (Yi et al., 2002). However, it has 
not been fully elucidated how E2-induced ERα regulation 
alleviates complications of diabetic mellitus (DM) in diabetics with 
E2 deficiency, although extensive studies have been performed on 
rodent models on the beneficial effects of E2 and ERα activation on 
glucose homeostasis and diabetes prevention (Bryzgalova et al., 
2006; Le et al., 2006). Indeed, reduced E2 may increase the 
incidence of diabetes by affecting the increased oxidative stress 
(Naziroglu et al., 2004), but the exact mechanisms of how E2 
signaling through ERα activates antioxidative enzymes and 
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modulates oxidative stress against hyperglycemia remain elusive. 
MSCs are widely used to treat cell transplantation, which 
prevents pathological changes and enhances regeneration in diabetic 
animals (Volarevic et al., 2011; Jackson et al., 2012). However, due 
to reduced cell survival in hyperglycemia by various stimuli such as 
hypoxia, oxidative stress, and inflammation, cell loss may result in 
decreased efficacy as a stem cell transplantation therapy (Li et al., 
2008; Raffaele et al., 2016). Indeed, many molecular and clinical 
data also support the effects of estrogen on normal skin 
homeostasis and wound healing. Furthermore, hyperglycemia or 
estrogen deficiency has harmful effects on the wound healing 
process. Even though E2 treatments in MSCs could effectively 
improve cell viability by modulating ROS levels, it is not known how 
E2 can increase the efficiency of treating injured tissues in diabetes 
through MSCs transplantation. Therefore, as the effects of E2 on 
wound healing are complicated, they require further investigation. 
In this study, in order to understand the effect of E2 and MSCs 
transplantation on tissue regeneration, the STZ-induced diabetic 
and ovariectomized (OVX) mice were utilized as a disease model. 
Although animal models have some limitation, such as in the type 1 
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DM model, this is not prevalent in the type 2 DM. Thus, the present 
study investigated the protective role of E2 in high glucose-
induced mtROS through ER-dependent signaling and assessed the 
effect of hUCB-MSC transplantation on mouse skin wound healing 
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2. MATERIALS AND METHODS 
 
2.1. Materials 
hUCB-MSCs were kindly provided from Kangstem Biotech 
(Seoul, Korea). FBS, PBS and α-MEM culture medium were 
purchased from GE healthcare life sciences (Pittsburgh, PA, USA). 
E2, streptozotocin (STZ), sesame oil, haematoxylin, eosin and 
sucrose were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
17β-Estradiol ELISA kit was purchased from Enzo life science 
(Seoul, Korea). SOD assay kit was obtained from Cayman chemical 
(Ann Arbor, MI, USA). EzSubcell fractionation kit and EzRIPA lysis 
kit were purchased from ATTO corporation (Tokyo, Japan). NAC, 
mitoTempo and Vas 2870 were purchased from Sigma-Aldrich (St. 
Louis, MO, USA). Primary antibodies against Beclin1 (sc-11427), 
ERα (sc-544), ERβ, Lamin A/C (sc-20681), and β-actin (sc-
47778) were purchased from Santa Cruz Biotechnology (Dallas, TX, 
USA). Secondary antibodies against HRP-conjugated goat anti-
rabbit IgG, goat anti-mouse IgG, and LC3 monoclonal primary 
antibody (MA5-17115) were purchased from Invitrogen (Thermo 
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Fisher Scientific, Waltham, MA, USA).  Ac-K68-SOD2 
(Ab137037) primary antibody were purchased from Abcam 
(Cambridge, MA, USA). Primary antibodies against LC3 (NB100-
2220) and p62 (NBP1-48320) were purchased from Novus 
(Littleton, CO, USA). Primary antibody against Sirt3 (5490s) was 
purchased from Cell signaling (Danvers, MA, USA). Primary 
antibody against Nrf2 (CSB-PA003481) and Keap1 (CSB-
PA012147LA01HU) were purchased from CusaBio (Houston, TX, 
USA) and MnSOD (06-984) primary antibody was purchased from 
EMD Millipore (Burlington, MA, USA).  
 
2.2. hUCB-MSC culture 
The general protocol for hUCB-MSC culture is described in 
Materials and Method section of CHAPTER II.  
 
2.3. Animal preparation 
All animal care and procedures were carried out in accordance 
with the National Institutes of Health Guidelines for the Humane 
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Treatment of Animals at Seoul National University and approved by 
the IACUC at Seoul National University (SNU-180314-2). Seven-
week-old female ICR mice weighing 22-25 g were purchased from 
Han Lim Experimental Animal (Suwon, Korea). Mice were stabilized 
in the new environment for four days before experimentation to 
improve animal welfare and experimental results. Animals were 
housed in groups of 5/cage and had ad libitum access to food and 
purified water. The house was kept under standard environmental 
conditions (24 ± 2 °C, 12/12 h light/dark cycle with lights on at 
07:00). After surgical procedures, the health status of all animals 
was checked three times a day. The animal allocation for each 
experimental group was randomized, which means that all surgical 
procedures and hUCB-MSC transplantation or drug injection were 
carried out blindly and the tissue sections were randomly selected 
from each animal. I was concerned with the “ 3R principle ” 
(reduction, replacement, refinement) in the context of animal 
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2.4. Experimental design 
Mice were randomly divided into two groups: Sham and OVX. All 
mice were anesthetized with 3% isoflurane in a mixture of N2O/O2 
gas. The bilateral OVX surgery in mice was performed by 
veterinarians. 8 days after the OVX surgery, mice were fasted for 6 
h before STZ injection. For diabetic induction, OVX mice were 
randomly selected and received intraperitoneal injection of 180 
mg/kg STZ with sodium citrate buffer (0.1 M, pH 4.5). An equal 
volume of sodium citrate buffer was injected into the mice in the 
non-diabetic group. Blood glucose levels were measured every 2 
days 48 h after STZ injection using Accu-Chek Active glucometer 
(Roche, Germany). Following STZ injection, mice developed mean 
blood glucose of 212.2 mg/dL within 4 days. 8 days after the STZ 
injection, the mean blood glucose was 316 mg/dL in the STZ group 
(Figure 25). Blood glucose levels that exceeded 250 mg/dL in mice 
were considered diabetic. The diabetic mice were randomly 
distributed among six groups (n=6 each group): OVX + STZ, OVX 
+ STZ +E2, OVX + STZ + NT siRNA +hUCB- MSCs, OVX + STZ 
+ NT siRNA + hUCB-MSCs + E2, OVX + STZ + ERα siRNA + 
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hUCB-MSCs + E2, and OVX + STZ + ERα siRNA + hUCB-MSCs. 
NT siRNA or ERα siRNA-transfected hUCB-MSC transplantation 
were performed for four groups: OVX + STZ + NT siRNA + 
hUCB-MSCs, OVX + STZ + NT siRNA + hUCB-MSCs + E2, OVX 
+ STZ + ERα siRNA + hUCB-MSCs + E2, and OVX + STZ + ER
α siRNA + hUCB-MSCs. To examine the role of E2 and hUCB-
MSC transplantation on tissue regeneration, the mouse skin wound 
splinting and stem cell transplantation were carried out according to 
the previous report (Wang et al., 2013). The detailed protocol for 
mouse excisional wound splinting model is described in Materials 
and Method section of CHAPTER II. All mice were anesthetized 
with a mixture of 80 mg/kg alfaxaline (Alfaxan™, Jurox Pty Ltd, 
Rutheford, Australia) and 10 mg/kg xylazine HCl (Rompun™, Bayer, 
Leverkusen, Germany). In the E2 treated groups, mice received 
intraperitoneal injection of 40 μg/kg E2, which was dissolved in 
sesame oil (Sigma-Aldrich, St. Louis, MO, USA) daily. 10 days 
after wounding, mice were euthanized so that wound tissues, uterus, 
and blood samples could be collected. To determine the effect of 
circulating E2, I measured the uterine weight and serum E2 from all 
mice. Figure 26 shows the uterine changes in sham and OVX mice. 
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As expected, the uterine weight significantly decreased in OVX with 
no E2 treatment groups (OVX, OVX + STZ, OVX + STZ + NT 
siRNA + hUCB-MSCs, and OVX + STZ + ERα siRNA + hUCB-
MSCs). In contrast, uterine weight significantly increased in all E2 
injection groups. Serum E2 levels were lower in all OVX without E2 
treatment groups when compared to the sham or all E2 treatment 
groups (Figure 27). The histology of uterus cross-sections 
revealed that uterine myometrium was thicker in all E2 injection 
groups than all OVX without E2 treatment groups (Figure 28). Skin 
and uterus tissues samples were fixed with 4% PFA for 4 h at room 
temperature. The tissues were incubated with 20% sucrose in PBS 
for dehydration until tissues subsided and were then incubated in 
30% sucrose at 4 °C overnight. The tissue samples were 
embedded with O.C.T. compound (Sakura Finetek, Torrance, CA, 














Figure 25. Effect of STZ on blood glucose in female mice with or 
without ovariectomy. Mice were stimulated with intraperitoneal 
injection of STZ (180 mg/kg, n = 15) or without STZ (vehicle ctrl, 
n = 47). Blood glucose concentration were measured every two 












Figure 26. Effect of E2 on uterine weight in female mice. Uterine 
weighs were measured immediately after tissue collections. Data 
are presented as mean ± SEM. n=3. *p < 0.05 versus sham group 










Figure 27. Effect of E2 on serum E2 of OVX diabetic mice. Blood 
samples were collected and serum E2 were measured by ELISA kit 
according to the manufacture’s protocol. *p < 0.05 versus sham 
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Figure 28. Effect of E2 on uterine myometrium thickness in OVX 
diabetic mice. Representative gross images of uterine cross-section 
are shown. Uterine tissues were randomized and stained by H&E 
staining and photographed under brightfield microscope. Uterine 
myometrium was measured by NIS-elements software (Ver. 4.6). 
Scale bar was set as 100 μm (Magnification х 100). Data are 
presented as mean ± SEM. n=3. *p < 0.05 versus sham group and 
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2.5. H&E staining 
The detailed protocol for H&E staining is described in Materials 
and Methods section of CHAPTER II.  
 
2.6. Western blot 
The detailed protocol for western blot is described in Materials 
and Methods section of CHAPTER II.  
 
2.7. Cell viability assay 
All procedures of cell viability assay were carried out according 
to manufacturer’s protocol. Cells were seeded in 96-well plates, 
and the medium was replaced with serum free media for 24 h prior 
to the experiments. 10 μL of EZ-Cytox reagent (Daeil Lab, Seoul, 
Korea) was added each wells and the cells were incubated for 2 h in 
37 °C incubator with 5% CO2 in the dark. The absorbance at 450 
nm was determined and analyzed with a multiplate reader (BioTek, 
Winooski, VT, USA). 
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2.8. SOD activity assay 
All procedures of SOD assay were carried out according to 
manufacturer’s protocol. Cells were harvested and centrifuged at 
1,000 х g for 10 min at 4 °C. Cells were lysed with cold 20 mM 
HEPES buffer (pH 7.2) containing 1 mM EGTA, 210 mM mannitol, 
and 70 mM sucrose by a Branson Sonifier 250 (Wilmington, NC, 
USA) with set to 3 of output power and duty cycle of 30% for 10 
sec and centrifuged at 1,500 х g for 5 min at 4 °C. The samples 
were diluted with the sample buffer, and the SOD standard and 
samples were added in a 96-well plate. Diluted xanthine oxidase 
was added to all wells. The 96-well plate was shaken gently for a 
several seconds and incubated on a shaking incubator for 30 min at 
room temperature. Absorbance at 450 nm was measured using a 
multiplate reader (BioTek, Winooski, VT, USA).  
 
2.9. 17β-Estradiol ELISA assay 
Blood samples were collected from all mice to obtain serum E2 
in heparinized tubes and centrifuged for 10 min at 3,000 rpm. The 
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supernatant was serum. The serum should be stored at -20 °C 
until just before analysis. All procedures of 17β-Estradiol ELISA 
assay were performed according to manufacturer’s protocol. The 
samples were added with conjugate solution and antibody in 
appropriate wells and were incubated at room temperature on a 
shaking incubator for 2 h at 250 rpm. After incubation, every wells 
were washed with wash buffer for three times. Next, p-Npp 
substrate solutions were added to every wells and the samples 
were incubated at room temperature for 45 min without shaking. 
After incubation, stop solution was added and the absorbance at 570 
nm was measured immediately using a multiplate reader (BioTek, 
Winooski, VT, USA).   
 
2.10. Cytosol and nuclear fractionation 
The detailed protocol for subcellular fractionation is described in 
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2.11. Transfection of siRNA 
The detailed protocol for siRNA transfection is described in 
Materials and Methods section of CHAPTER II. Cells were 
transfected for 24 h with either a siRNA specific for ATG5, ERα, 
SIRT3, MnSOD, NRF2 or a NT siRNA as a negative control (25 pM; 
Bioneer and 20 nM; Dharmacon) using TurboFECT transfection 
reagent. The sequences of siRNA used in the study were as 
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Table 2. Sequences of the siRNAs and its suppliers used for gene 
silencing. 
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2.12. Intracellular ROS detection 
The detailed protocol for intracellular ROS detection is described 
in Materials and Methods section of CHAPTER II.  
 
2.13. Immunofluoresence staining 
The detailed protocol for immunofluorescence staining is 
described in Materials and Methods section of CHAPTER II. Images 
were visualized by super-resolution radial fluctuations (SRRF) 
imaging system (Andor Technology, Belfast, UK) or fluorescence 
microscopy (Nikon Corporation, Tokyo, Japan). The fluorescent 
intensity was analyzed using Fiji software (NIH, Bethesda, MD, 
USA).   
 
2.14. Flow cytometry 
Cells were seeded in 60 mm diameter culture dish. Media were 
replaced with serum-free media for 24 h when cells were at 70% 
confluence. Cells were stained with 5μM MitoSox for 15 min. Cells 
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were washed with PBS and treated with trypsin to detach cells from 
the dish. Cells were centrifuged at 250 х g for 3 min. MitoSox 
staining was determined with flow cytometry (Beckman Coulter, 
Atlanta, GA). 
 
2.15. Statistical analysis 
All data are represented as mean ± standard error of mean 
(SEM). Statistical analysis was carried out by using GraphPad 
Prism Version 5.0 (GraphPad Inc., San Diego, CA, USA) and 
ANOVA. In some cases, the Bonferroni-Dunn test was used for 











3.1. Effect of E2 on high glucose-induced autophagic 
cell death 
To confirm the effect of high glucose on autophagy in hUCB-
MSCs, cells were incubated under high glucose conditions (25 mM) 
at various times ranging from 0 to 72 h. High glucose significantly 
enhanced Beclin1 at 48 h and LC3-II/LC3-I ratio at 48 h and 72 h 
while p62 expression decreased gradually after 48 h (Figure 29). In 
addition, cell viability was decreased in a time-dependent manner 
under high glucose conditions (Figure 30). To investigate the 
involvement of high glucose on autophagic cell death, I carried out 
ATG5 siRNA transfection to inhibit autophagosome (Chen et al., 
2008) and analyzed the cell viability. My results show that high 
glucose-reduced cell viability was restored following transfection 
of siRNA against ATG5 (Figure 31). To determine the effect of E2 
on autophagy in hUCB-MSCs, autophagy-related proteins were 
identified by western blot analysis. High glucose increased Beclin1 
expression and the LC3-II/LC3-I ratio while p62 expression 
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decreased, which were reversed by E2 treatment (10 nM) (Figure 
32A). Consistent with these results, immunofluorescence results 
showed that high glucose-induced LC3 puncta were decreased by 
E2 treatment. In addition, high glucose-reduced p62 was restored 
by E2 treatment (Figure 32B). To evaluate the role of E2 on cell 
viability under high glucose conditions, a cell viability assay was 
carried out. My results showed that high glucose-reduced cell 
viability was significantly recovered by E2 treatment under high 
glucose conditions (Figure 33). Taken together, these data suggest 
that high glucose induces autophagic cell death and E2 has a 
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Figure 29. Effect of high glucose on autophagy-related proteins in 
hUCB-MSCs. Cells were incubated with high glucose (D-glucose, 
25 mM) for various times (0-72 h) where the total cell lysates 
were detected by western blot with antibodies that recognize 
Beclin1, LC3 and p62. β-actin was used as a loading control. 
Beclin1, the LC3 ratio and p62 were quantified with ImageJ 
software. Data are presented as mean ± SEM. n=3. *p < 0.05 
versus 0 h of Beclin1, &p < 0.05 versus 0 h of the LC3-II/LC3-I 
ratio, and $p < 0.05 versus 0 h of p62.  
  







Figure 30. Effect of high glucose on survival of hUCB-MSCs. Cells 
were incubated with high glucose for various times (0-72 h) where 
the cell viability was determined by measuring absorbance at 450 
nm using a multiplate reader. Data are presented as mean ± SEM. 










Figure 31. Effect of high glucose on autophagic cell death in hUCB-
MSCs. Cells were transfected with ATG5 siRNA (25 pM) or NT 
siRNA for 24 h prior to high glucose treatment for 72 h where the 
cell viability was determined by measuring absorbance at 450 nm 
using a multiplate reader. Data are presented as mean ± SEM. n=5. 
*p < 0.05 versus ctrl with NT siRNA and #p < 0.05 versus high 
glucose with NT siRNA.  
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Figure 32. Effect of E2 on autophagy in hUCB-MSCs. (A) Cells 
were treated with E2 for 6 h prior to high glucose treatment for 48 
h where the expression of Beclin1, LC3 and p62 were detected by 
western blot. β-actin was used as a loading control. Beclin1, the 
LC3 ratio and p62 were quantified with ImageJ software. Data are 
presented as mean ± SEM. n=3. *p < 0.05 versus ctrl of Beclin1, 
#p < 0.05 versus high glucose of Beclin1, &p < 0.05 versus ctrl of 
LC3-II/LC3-I ratio, $p < 0.05 versus high glucose of LC3-II/LC3-
I ratio, @p < 0.05 versus ctrl of p62, and +p < 0.05 versus high 
glucose of p62. (B) Cells were treated with E2 for 6 h prior to high 
glucose treatment for 48 h. The expression of LC3 and p62 were 
detected by immunofluorescence staining and visualized by SRRF 
imaging system. Scale bar was set as 20 μm (Magnification х 
1,000). Data are presented as mean ± SEM. n=3. Representative 
gross images of LC3 and p62 were quantified with Fiji software. *p 
< 0.05 versus ctrl of LC3, #p < 0.05 versus high glucose of LC3, 












Figure 33. Effect of E2 on survival of hUCB-MSCs. Cells were 
treated with E2 for 6 h prior to high glucose treatment for 72 h 
where the cell viability was determined by measuring absorbance at 
450 nm using a multiplate reader. Data are presented as mean ± 






- 132 - 
 
3.2. Effect of E2 on high glucose-induced mtROS 
High glucose is well known to induce excessive production of 
ROS, and an increase in ROS triggers the dysfunction of 
mitochondria. To examine the role of high glucose on ROS 
accumulation in hUCB-MSCs, the ROS level was examined by using 
DCF-DA (10 μM) where the ROS level was increased in a time-
dependent manner (Figure 34A). However, E2 treatment under high 
glucose conditions decreased ROS levels compared to high glucose 
alone (Figure 34B). To investigate where ROS occurs within the 
cells in high glucose conditions, I pretreated NAC (10 µM), 
mitoTempo (20 µM), and Vas2870 (10 µM) for 30 min prior to high 
glucose treatments in hUCB-MSCs. High glucose-induced ROS 
was blocked by NAC and mitoTempo, but Vas2870 did not impact 
the ROS levels under high glucose conditions (Figure 35A). 
Mitochondria produce a massive amount of ROS to play an important 
role in autophagy. To determine the induction of autophagy by 
mtROS, I analyzed the expression of autophagy-related proteins 
with mitoTempo pretreatment by western blot. In my results, the 
protein levels of Beclin1 and the LC3-II/LC3-I ratio were reduced 
by mitoTempo pretreatment under high glucose conditions. In 
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contrast, high glucose-reduced p62 was increased by mitoTempo 
pretreatment (Figure 35B). To determine the effect of E2 on high 
glucose-induced mtROS, hUCB-MSCs were stained with 
MitoTracker Green and MitoSox Red. E2 efficiently abolished 
mtROS generated by high glucose in hUCB-MSCs (Figure 36A). 
Consequently, high glucose evoked mtROS while E2 efficiently 
abolished mtROS generated by high glucose in hUCB-MSCs (Figure 
36B). These data indicate that high glucose induces autophagy 
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Figure 34. Effect of E2 on high glucose-induced ROS in hUCB-
MSCs. (A) Cells were incubated with high glucose for various times 
(0-72 h) where DCF-DA was detected by luminometer. Data are 
presented as mean ± SEM. n=3. *p < 0.05 versus 0 h. (B) Cells 
were treated with E2 for 6 h prior to high glucose treatment for 48 
h where DCF-DA was detected by luminometer. Data are presented 
as mean ± SEM. n=5. *p < 0.05 versus ctrl and #p < 0.05 versus 
high glucose alone. 
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Figure 35. Effect of high glucose on mtROS in hUCB-MSCs. (A) 
Cells were pretreated with either NAC (10 μM), mitoTempo (20 
μM) or Vas2870 (10 μM) for 30 min prior to high glucose 
treatment for 48 h where DCF-DA was detected by luminometer. 
Data are presented as mean ± SEM. n=5. *p < 0.05 versus ctrl and 
#p < 0.05 versus high glucose alone. (B) Cells were pretreated 
with mitoTempo (20 μM) for 30 min prior to high glucose 
treatment for 48 h where the expression of Beclin1, LC3 and p62 
were detected by western blot. β-actin was used as a loading 
control. Beclin1, the LC3-II/LC3-I ratio and p62 were quantified 
with ImageJ software. Data are presented as mean ± SEM. n=3. *p 
< 0.05 versus ctrl of Beclin1, #p < 0.05 versus high glucose of 
Beclin1, &p < 0.05 versus ctrl of LC3-II/LC3-I ratio, $p < 0.05 
versus high glucose of LC3-II/LC3-I ratio, @p < 0.05 versus ctrl 
of p62, and +p < 0.05 versus high glucose of p62. 
  





- 139 - 
 
Figure 36. Effect of E2 on high glucose-induced mtROS in hUCB-
MSCs. (A) Cells were treated with E2 for 6 h prior to high glucose 
treatment for 48 h. Mitotracker Green (MTG; 200 nM; green) and 
Mitosox Red (MSR; 5 μM; red) were detected by immuno-
fluorescence staining and visualized by confocal microscopy. Scale 
bar was set as 100 μm (Magnification х 200). (B) Cells were 
treated with E2 for 6 h prior to high glucose treatment for 48 h 
where mtROS with mitoSox was measured using FACS analysis. 
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3.3. Involvement of ERα on the upregulation of Nrf2 
and Sirt3 
To assess the effect of estrogen receptors by E2 under high 
glucose conditions, I performed western blot after isolating the 
cytosol and nuclear fractionation. ERα was in high abundance in 
the nucleus after E2 treatment under high glucose conditions when 
compared to control or high glucose only. In contrast, E2 treatment 
did not affect ERβ expression in the nucleus under high glucose 
conditions (Figure 37). Therefore, to confirm the role of high 
glucose-reduced Nrf2 in the nucleus by regulating ERα, ERα 
siRNA transfection was carried out. ERα siRNA-transfected cells 
decreased the nuclear Nrf2 level under high glucose conditions 
(Figure 38A) whereas high glucose did not change the nuclear Nrf2 
by ERβ siRNA transfection (Figure 38B). To assess the effect of 
ERα on Sirt3 expression, ERα siRNA transfection was carried out. 
NT siRNA-transfected hUCB-MSCs reduced Sirt3 expression 
under high glucose conditions compared to NT siRNA-transfected 
cells. In addition, ERα siRNA transfection decreased Sirt3 
expression more than NT siRNA-transfected hUCB-MSCs with 
high glucose (Figure 39). ERα siRNA-transfected cells after high 
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glucose treatment decreased the SOD activity compared to NT 
siRNA-transfected cells with high glucose (Figure 40). Therefore, 
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Figure 37. Effect of E2 on high glucose-induced ERα nuclear 
translocation. Cells were treated with E2 for 6 h prior to high 
glucose treatment for 48 h where the subcellular fractionation was 
carried out according to the manufacturer’s protocol. The 
expression of ERα and ERβ were detected by western blot. β-
actin was used as the cytosol marker and Lamin A/C was used as 
the nuclear marker. ERα and ERβ were quantified with ImageJ 
software. Data are presented as mean ± SEM. n=3. *p < 0.05 
versus ctrl of ERα in cytosol, &p < 0.05 versus ctrl of ERα in 
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Figure 38. Effect of high glucose on ERα-dependent Nrf2 nuclear 
translocation. (A) Cells were transfected with ERα siRNA or NT 
siRNA for 24 h prior to high glucose treatment for 72 h where 
nuclear fraction was carried out. Nuclear Nrf2 was detected by 
western blot. Lamin A/C was used as the nuclear marker. Nuclear 
Nrf2 was quantified with ImageJ software. Data are presented as 
mean ± SEM. n=3. *p < 0.05 versus ctrl with NT siRNA and #p < 
0.05 versus high glucose with NT siRNA. (B) Cells were 
transfected with ERβ siRNA or NT siRNA for 24 h prior to high 
glucose treatment for 72 h where nuclear fraction was carried out. 
Nuclear Nrf2 was detected by western blot. Lamin A/C was used as 
the nuclear marker. Nuclear Nrf2 was quantified with ImageJ 
software. Data are presented as mean ± SEM. n=3. *p < 0.05 














Figure 39. Effect of high glucose on ERα-dependent Sirt3 
upregulation. Cells were transfected with ERα siRNA or NT siRNA 
for 24 h prior to high glucose treatment for 72 h where Sirt3 
expression was detected by western blot. β-actin was used as a 
loading control. Sirt3 was quantified with ImageJ software. Data are 
presented as mean ± SEM. n=3. *p < 0.05 versus ctrl with NT 
siRNA and #p < 0.05 versus high glucose with NT siRNA. 
 
  






Figure 40. Effect of high glucose on SOD activity through ERα 
signaling. Cells were transfected with ERα siRNA or NT siRNA for 
24 h prior to high glucose treatment for 72 h where SOD activity 
assay was carried out. Absorbance at 450 nm was measured with a 
multiplate reader. Data are presented as mean ± SEM. n=3. *p < 
0.05 versus ctrl with NT siRNA and #p < 0.05 versus high glucose 
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3.4. Role of E2 on Nrf2-dependent mtROS under high 
glucose conditions 
Nrf2/Keap1 signaling causes a protective mechanism against the 
deleterious effects of oxidative stress. In particular, Nrf2 is a 
transcription factor that regulates many antioxidant enzyme gene 
expressions, such as MnSOD and catalase (Li et al., 2004). 
Therefore, to examined whether ROS levels which were increased 
by high glucose were affected by Nrf2, I measured ROS levels after 
performing NRF2 siRNA transfection with high glucose treatment. 
In my results, NRF2 silencing enhanced ROS levels under high 
glucose conditions compared to NT siRNA-transfected cells with 
high glucose (Figure 41). To confirm the effect of high glucose on 
Nrf2 nuclear translocation, nuclear fractionation was performed. 
High glucose treatment for 72 h decreased the levels of nuclear 
Nrf2, whereas it increased the levels of Keap1 in the total cell 
lysates (Figure 42A). In addition, the nuclear translocation of Nrf2 
was inhibited by high glucose treatment for 72 h (Figure 42B). 
Furthermore, the knockdown of NRF2 further decreased Sirt3 and 
MnSOD expression levels under high glucose conditions (Figure 43). 
To verify the effect of E2 on Nrf2 nuclear translocation under high 
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glucose conditions, nuclear fraction was carried out after E2 
treatment under high glucose conditions. E2 treatment restored the 
nuclear Nrf2 levels under high glucose conditions while high 
glucose decreased nuclear Nrf2 levels (Figure 44A). Consistent 
with these results, immunofluorescence results showed that Nrf2 
present in the cytoplasm accumulated around the nucleus by E2 
treatment under high glucose conditions. Nrf2 was upregulated in 
response to E2 treatment under high glucose conditions, but the 
loss of Nrf2 was observed in the nucleus by high glucose (Figure 
44B). Collectively, these results indicate that high glucose enhances 
















Figure 41. Effect of high glucose on ROS through Nrf2 signaling in 
hUCB-MSCs. Cells were transplanted with NRF2 siRNA or NT 
siRNA for 24 h prior to high glucose treatment for 48 h where 
DCF-DA was detected by luminometer. Data are presented as 
mean ± SEM. n=5. *p < 0.05 versus ctrl with NT siRNA and #p < 
0.05 versus high glucose with NT siRNA. 
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Figure 42. Effect of high glucose on decreased Nrf2 nuclear 
translocation in hUCB-MSCs. (A) Cells were incubated with high 
glucose for various times (0-72 h) where nuclear fraction was 
carried out. Nuclear Nrf2 and the total Keap1 were detected by 
western blot. Lamin A/C was used as the nuclear marker. β-actin 
was used as a loading control. Nuclear Nrf2 and total Keap1 were 
quantified with ImageJ software. Data are presented as mean ± 
SEM. n=3. *p < 0.05 versus 0 h of nuclear Nrf2 and &p < 0.05 
versus 0 h of Keap1. (B) Cells were treated with high glucose for 
72 h where the subcellular fractionation was carried out. Nrf2 was 
detected by western blot. β-actin was used as the cytosol marker 
and Lamin A/C was used as the nuclear marker. Nrf2 was quantified 
with ImageJ software. Data are presented as mean ± SEM. n=3. *p 
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Figure 43. Effect of high glucose on Sirt3 and MnSOD repression 
through Nrf2 signaling in hUCB-MSCs. Cells were transfected with 
NRF2 siRNA or NT siRNA for 24 h prior to high glucose treatment 
for 72 h where Sirt3 and MnSOD were detected by western blot. 
β-actin was used as a loading control. Sirt3 and MnSOD were 
quantified with ImageJ software. Data are presented as mean ± 
SEM. n=3. *p < 0.05 versus ctrl of Sirt3 with NT siRNA, #p < 0.05 
versus high glucose of Sirt3 with NT siRNA, &p < 0.05 versus ctrl 
of MnSOD with NT siRNA, and $p < 0.05 versus high glucose of 
MnSOD with NT siRNA. 
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Figure 44. Effect of E2 on Nrf2 nuclear translocation in hUCB-MSCs. 
(A) Cells were treated with E2 for 6 h prior to high glucose 
treatment for 72 h where nuclear fraction was carried out. Nuclear 
Nrf2 was detected by western blot. Lamin A/C was used as the 
nuclear marker. Nuclear Nrf2 was quantified with ImageJ software. 
Data are presented as mean ± SEM. n=3. *p < 0.05 versus ctrl and 
#p < 0.05 versus high glucose alone. (B) Cells were treated with 
E2 for 6 h prior to high glucose treatment for 72 h, and the 
expression of Nrf2 was detected by immunofluorescence staining 
and visualized by SRRF imaging system. Scale bar was set as 20 
μm (Magnification х 1,000). Data are presented as mean ± SEM. 
n=3. Representative gross images of Nrf2 was quantified with Fiji 
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3.5. Role of E2 on Sirt3-dependent MnSOD in the 
mtROS production under high glucose conditions 
To verify that MnSOD regulates ROS in high glucose conditions, I 
investigate the change in the MnSOD acetylation at lysine 68 (Ac-
K68-MnSOD), because the lysine site of MnSOD is known to be the 
most important acetylation site for activating MnSOD. My results 
reveal that high glucose increased the Ac-K68-MnSOD level in a 
time-dependent manner whereas the MnSOD expression level was 
decreased under high glucose conditions (Figure 45A). Sirt3, a 
nicotinamide adenine dinucleotide (NAD+)-dependent mitochondrial 
deacetylase, plays an essential role in regulating high 
glucose/diabetes-induced ROS generation (Jing et al., 2011; Zhang 
et al., 2013). In time-course experiments, the expression level of 
Sirt3 was decreased by high glucose treatment (Figure 45B). Sirt3 
directly deacetylases MnSOD, indicating the promotion of its 
antioxidative activity (Qiu et al., 2010). Thus, to verify the effects 
of Sirt3 on MnSOD activation, SIRT3 siRNA transfection was 
carried out. SIRT3 knockdown induced MnSOD acetylation under 
high glucose conditions (Figure 46), indicating the activation of 
MnSOD by Sirt3. Next, I tested that MnSOD present in the 
mitochondria matrix regulates ROS. MnSOD silencing under high 
glucose conditions significantly increased ROS levels compared to 
NT siRNA-transfected hUCB-MSC with high glucose (Figure 47). 
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To verify the effects of E2 on Sirt3 expression under high glucose 
conditions, western blot was carried out. My results show that high 
glucose induced Sirt3 repression while E2-treated high glucose 
increased Sirt3 expression when compared to high glucose alone in 
hUCB-MSCs (Figure 48A). Consequently, immunofluorescence 
staining indicated that Sirt3 was decreased by high glucose 
treatment, which was reversed by treatment with E2 under high 
glucose conditions (Figure 48B). To verify the protective role of E2 
on SOD activity, a SOD activity assay was performed. The level of 
SOD activity decreased significantly in high glucose-treated 
hUCB-MSCs compared to control. Furthermore, E2 treatment 
under high glucose conditions recovered the SOD activity compared 
to high glucose only (Figure 49). Hence, these findings suggest that 
E2 treatment enhanced Sirt3-dependent MnSOD activation under 
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Figure 45. Effect of high glucose on MnSOD activation and Sirt3 
expression in hUCB-MSCs. (A) Cells were incubated with high 
glucose for various times (0-72 h) where Ac-K68-MnSOD and 
MnSOD were detected by western blot. β-actin was used as a 
loading control. Ac-K68-MnSOD and MnSOD were quantified with 
ImageJ software. Data are presented as mean ± SEM. n=3. *p < 
0.05 versus 0 h of Ac-K68-MnSOD and &p < 0.05 versus 0 h of 
MnSOD. (B) Cells were incubated with high glucose for various 
times (0-72 h) and Sirt3 was detected by western blot. β-actin 
was used as a loading control. Sirt3 was quantified with ImageJ 
software. Data are presented as mean ± SEM. n=3. *p < 0.05 
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Figure 46. Effect of high glucose on MnSOD activation through Sirt3 
signaling in hUCB-MSCs. Cells were transfected with SIRT3 siRNA 
or NT siRNA for 24 h prior to high glucose treatment for 72 h 
where Ac-K68-MnSOD and MnSOD were detected by western blot. 
β-actin was used as a loading control. Ac-K68-MnSOD and 
MnSOD were quantified with ImageJ software. Data are presented 
as mean ± SEM. n=3. *p < 0.05 versus ctrl of Ac-K68-MnSOD 
with NT siRNA, #p < 0.05 versus high glucose of Ac-K68-MnSOD 
with NT siRNA, &p < 0.05 versus ctrl of MnSOD with NT siRNA, 
and $p < 0.05 versus high glucose of MnSOD with NT siRNA. 
  







Figure 47. Effect of high glucose on ROS production through MnSOD 
signaling in hUCB-MSCs. Cells were transplanted with MnSOD 
siRNA or NT siRNA for 24 h prior to high glucose treatment for 72 
h where DCF-DA was detected by luminometer. Data are presented 
as mean ± SEM. n=5. *p < 0.05 versus ctrl with NT siRNA and #p 
< 0.05 versus high glucose with NT siRNA. 
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Figure 48. Effect of E2 on high glucose-induced Sirt3 repression in 
hUCB-MSCs. (A) Cells were treated with E2 for 6 h prior to high 
glucose treatment for 72 h where Sirt3 was detected by western 
blot. β-actin was used as a loading control. Sirt3 was quantified 
with ImageJ software. Data are presented as mean ± SEM. n=3. *p 
< 0.05 versus ctrl and #p < 0.05 versus high glucose alone. (F) 
Cells were treated with E2 for 6 h prior to high glucose treatment 
for 72 h where the expression of Sirt3 was detected by 
immunofluorescence staining and visualized by SRRF imaging 
system. Scale bar was set as 20 μm (Magnification х 1,000). 
Data are presented as mean ± SEM. n=3. Representative gross 
images of Sirt3 was quantified with Fiji software. *p < 0.05 versus 


















Figure 49. Effect of E2 on SOD activity under high glucose conditions 
in hUCB-MSCs. Cells were treated with E2 for 6 h prior to high 
glucose treatment for 72 h where SOD activity assay was carried 
out. Absorbance at 450 nm was measured with a multiplate reader. 
Data are presented as mean ± SEM. n=5. *p < 0.05 versus ctrl and 
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3.6. Role of E2 on the mouse skin wound healing 
effect via ERα signaling in OVX diabetic mice 
I have found that E2 has protective effects on the mtROS-
induced autophagic cell death in hUCB-MSCs under high glucose 
conditions. Thus, I examined the functional role of E2 by which E2 
treatment may affect wound healing on the in vivo OVX diabetic 
mouse model. To confirm the effect of ERα on hUCB-MSCs in 
OVX diabetic mice, I transfected ERα siRNA into hUCB-MSCs 
before injecting it into the mouse wound sites. In my results, the 
wound closure effect in the OVX + STZ + E2 group did not show a 
significant difference from the OVX + STZ group on day 9 (p > 
0.05). Interestingly, the wound healing effect in OVX + STZ + NT 
siRNA + hUCB-MSC + E2 was significantly higher than in the OVX 
+ STZ + NT siRNA + hUCB-MSC group 9 days after wounding. In 
addition, the wound healing effect was significantly reduced in OVX 
+ STZ + ERα siRNA + hUCB-MSC + E2 compared to the OVX + 
STZ + NT siRNA + hUCB-MSC + E2 group. The OVX + STZ 
group had a similar wound size as other groups on day 6, but the 
wound size was observed to be the largest 9 days after wounding 
(Figure 50A and 50B). Histological examination of wound tissues on 
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day 10 showed that the wound site was almost filled with 
granulation tissues for OVX + STZ + NT siRNA + hUCB-MSC + 
E2 compared to the wounds of OVX + STZ + ERα siRNA + 
hUCB-MSC + E2 group (Figure 51). To track transplanted hUCB-
MSC in vivo on day 10, wound tissues were stained with anti-
human nuclear antigen (HNA) antibodies. Immunohistochemistry 
revealed many HNA-positive cells in the OVX + STZ + NT siRNA 
+ hMSC + E2 group, while no HNA-positive cells were found in 
the Sham / OVX / OVX+STZ / OVX + STZ + E2 group (Figure 52). 
Blood vessels that developed many branches were observed in all 
hUCB-MSC transplantation groups compared to the no hUCB-MSC 
transplantation groups. In particular, developed blood vessels were 
observed in the OVX + STZ + NT siRNA + hUCB-MSC + E2 
group compared to other hUCB-MSC transplantation groups. Blood 
vessels that reduced branches were observed in OVX + STZ + ER
α siRNA + hUCB-MSC + E2 groups compared to OVX + STZ + 
NT siRNA + hUCB-MSC + E2 groups (Figure 53). Overall, these 
data indicate that transplantation of hUCB-MSCs with E2 injection 
into OVX diabetic mice results in faster wound healing than E2 
injection only or hUCB-MSC transplantation only.  
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Figure 50. Effect of ERα-silenced hUCB-MSC transplantation with 
E2 injection in OVX diabetic mouse model. (A) OVX diabetic mice 
were randomly divided into six groups (n=6 each group): OVX + 
STZ, OVX + STZ + E2, OVX + STZ + NT siRNA + hUCB-MSC 
(MSC), OVX + STZ + NT siRNA + MSC + E2, OVX + STZ + ERα 
siRNA + MSC + E2, and OVX + STZ + ERα siRNA + MSC. 
Representative gross images of wounds on days 0, 3, 6, and 9 are 
shown. (B) Percentage of wound sizes on days 0, 3, 6, and 9 are 
shown. Wound sizes were measured with ImageJ software. Data are 
presented as mean ± SEM. n=6 each group. *p < 0.05 versus OVX 
+ STZ + ERα siRNA + MSC + E2 group and #p < 0.05 versus 
















Figure 51. Effect of ERα-silenced hUCB-MSC transplantation in 
OVX diabetic mouse model. Wound tissues were stained by H&E 
staining and photographed under brightfield microscopy. Scale bars 
were set as 200 μm or 100 μm. 
 
  




Figure 52. Effect of ERα-silenced hUCB-MSC transplantation on 
HNA expression in OVX diabetic mouse model. Wound tissues were 
immunostained with HNA (green) and DAPI (blue), before being 
visualized by fluorescence microscopy. Scale bar was set as 100 
μm (Magnification х 100). The percentage of HNA-positive cells 











Figure 53. Effect of ERα-silenced hUCB-MSC transplantation with 
E2 injection on blood vessel formation in OVX diabetic mouse model.  
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4. DISCUSSION 
In the present study, I showed that E2 (10 nM) has a protective 
effect on high glucose (25 mM)-induced mtROS generation and 
autophagic cell death through ERα-dependent signaling including 
nuclear translocation of Nrf2 and subsequent Sirt3-induced MnSOD 
activation in hUCB-MSCs (Figure 54). Moreover, this study 
demonstrated that the therapeutic efficacy of hUCB-MSCs in 
mouse cutaneous wound healing model with E2 deficiency and 
diabetes was enhanced by E2 treatment (40 μg/kg/day). Since 
high glucose regulates the intracellular signaling cascade of ROS 
through a variety of intracellular events and induces excessive ROS 
generation, the exposure to high glucose eventually leads to cell 
toxicity including cell death in various types of cells (Yu et al., 
2011; Zhao et al., 2015) as well as a therapeutic efficacy reduction 
of cells (Raffaele et al., 2016). In bone marrow-derived MSC, high 
glucose exposure regulates ROS-induced senescence, which is 
associated with enhanced autophagy and leads to shutting down the 
apoptotic process (Chang et al., 2015). However, my data indicate 
that high glucose causes mitochondrial dysfunction through 
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excessive ROS production, consequently leading to autophagic cell 
death. According to the previous reports, exposure to high glucose 
affects cell death by autophagy dysfunction (Wang et al., 2015) and 
high glucose is known to regulate autophagy through mitochondrial 
damage by increasing oxidative stress (Park and Park, 2013). For 
this reason, reducing the mtROS levels can restore mitochondrial 
damage and autophagy dysfunction, which may prevent oxidative 
stress-induced diabetes-associated diseases. 
  E2 can be considered an important antioxidant for cytoprotection 
to reduce the excessive ROS generation by high glucose. Thus, in 
the present study, I demonstrated that treatment of E2 attenuates 
mtROS production and facilitates cell survival under high glucose 
exposure. Earlier studies showed that E2 enhances mitochondrial 
efficiency and suppresses mtROS through increased MnSOD by 
reduced superoxide production (Razmara et al., 2007; Stirone et al., 
2005). In addition, E2 induces in mitochondrial protection through 
ROS reduction, decreasing mitochondrial membrane potential and 
ATP depletion in an ER-dependent manner under ischemic states in 
which oxygen and glucose transfer were insufficient (Guo et al., 
2012). However, under high glucose conditions, my data reveal that 
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a potential role of E2 through translocation of ERα upregulates 
antioxidant enzymes that directly target high glucose-mediated 
ROS generation, finally decreasing autophagic cell death. Many 
reports have demonstrated that hyperglycemia leads to decreased 
ERα in diabetic animals (Cushman et al., 2009; Kim et al., 2006). 
Furthermore, ERα expression was downregulated by 
glucolipotoxicity in old rats and can alter their resistance to diabetic 
injuries since ERα enhances the survival rate (Kilic et al., 2014). 
Thus, I confirmed that E2 could inhibit the generation of mtROS and 
autophagic cell death by high glucose exposure in an ERα-
dependent manner. 
Since E2 binds with ERα to inhibit Nrf2-mediated transcription 
in breast cancer cells, it has been suggested that the function of ER
α should be minimized for Nrf2 activation (Ansell et al., 2005; Yao 
et al., 2010). However, in my results, Nrf2 translocation into the 
nucleus was inhibited by ERα siRNA transfection under high 
glucose conditions. Nrf2 is a crucial transcription factor that 
protects against oxidants and increases cell survival in many 
tissues. In addition, Nrf2 plays an important role in maintaining 
cellular redox homeostasis by regulating the ROS production by 
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NADPH oxidase. Nuclear Nrf2 binds to the antioxidant-related 
elements and expresses antioxidant genes such as MnSOD and 
catalase, thus cellular protection by ROS suppression. Many studies 
have shown that Keap1 binds to Nrf2 and degrades through the 
proteasomal degradation process in unstressed conditions or basal 
conditions while Nrf2 is activated and translocated to the nucleus by 
oxidative stress (Kobayashi et al., 2006; Zhang, 2006). However, in 
my results, nuclear Nrf2 is decreased by high glucose while the 
levels of Keap1 are elevated in a time-dependent manner. This 
seems to be a deficit in the function of Nrf2 when exposed long-
term to high glucose, which may contribute to oxidative stress-
mediated diabetic complications. Indeed, Nrf2 expression is reduced 
in the late-stage diabetic/insulin resistance model (Miao et al., 
2012; Tan et al., 2011). Together, these results suggest that ERα 
plays a key role in enhancing nuclear Nrf2 under high glucose 
conditions.  
Moreover, my data reveal that ERα silencing decreased Sirt3 
expression more than cells with high glucose treatment. Sirtuin is 
an NAD+-dependent deacetylase involved in energy metabolism, 
DNA repair, and stress response. Sirt3 activates antioxidant 
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enzymes, such as MnSOD, through deacetylation. Therefore, the 
most persuasive interpretation of my results is that E2 leads to the 
activation of MnSOD by inducing functional Sirt3. Indeed, ERα 
silencing attenuated the SOD activation under high glucose 
conditions, suggesting a molecular cross-talk blocking Sirt3. In the 
current study, the main issue is how E2 enhancing Sirt3 expression 
through genomic signaling may attenuate the ROS production in 
hUCB-MSCs. Recent studies demonstrated that Sirt3 reduced high 
glucose-induced cytotoxicity and cell senescence (Zhang et al., 
2013; Liu et al., 2015). Therefore, I demonstrated that high glucose 
attenuates Sirt3 expression and induces MnSOD acetylation. 
Although there are various ways to reduce high glucose-induced 
mtROS, I found that Sirt3 and MnSOD-induced mtROS reduction 
through E2-induced ERα signaling under high glucose conditions. 
Thus, I suggest that E2 treatment enhances Sirt3 and MnSOD 
expressions under high glucose conditions and increases in Sirt3 
and MnSOD may reduce autophagic cell death for cellular protection. 
Although the exact mechanism of E2-dependent ERα signaling is 
unknown in mitochondrial dysfunction and cell protection, I have 
proven that Nrf2 and Sirt3 have the effects to regulate MnSOD-
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induced mtROS reduction under high glucose conditions, suggesting 
that E2 plays an important role in enhancing the hUCB-MSC 
protection through ERα signaling pathways.  
In this study, I observed that E2 treatment with hUCB-MSC 
transplantation facilitates tissue repair and vascular regeneration in 
vivo. Although I anticipated that E2 treatment by itself has the 
ability to improve wound healing, wound closure rates were not 
significantly different between the OVX + STZ + E2 group and the 
OVX + STZ group. According to epidemiological data, the degree 
and duration of hyperglycemia is related to microvascular 
complications of diabetes (Ohkubo et al., 1995; Valeri et al., 2004). 
In addition, the therapeutic effect of E2 has very narrow index 
when exposed to chronic or long-term diabetes (Mauvais-Jarvis et 
al., 2017). Thus, it is possible that the hyperglycemic conditions 
may be considered to decrease the therapeutic effect of E2 in OVX 
diabetic mice. My results also indicated that the wounds are almost 
closed and filled with granulation tissues by E2-treated hUCB-
MSC transplantation in OVX diabetic mice model. Thus, it is 
possible that hUCB-MSC transplantation with E2 treatment may be 
more effective for wound healing than hormone therapies with E2 or 
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hUCB-MSC transplantation. My data observed that ERα siRNA-
transfected hUCB-MSC transplantation is not affected by the E2 
treatment in OVX diabetic mice. Therefore, my observations 
suggest that hUCB-MSC transplantation efficiency facilitates when 
circulating E2 is processed while ERα silencing reduces hUCB-
MSC transplantation efficiency and delays skin wound healing in 
OVX diabetic mice, suggesting a more predominate role for ERα in 










Figure 54. The schematic model for mechanism in the protective 
effect of E2 on high glucose-induced mtROS through ERα-
dependent Nrf2 and Sirt3 upregulation in hUCB-MSCs. Hypothetical 
model for E2-induced ERα signaling under high glucose conditions 
in hUCB-MSCs. Red arrows represent E2-induced ERα signaling 
pathways shown. Blue arrows represent high glucose-induced 
autophagic cell death signaling pathways shown. Abbreviations: E2, 
17β-estradiol; ERα, estrogen receptor alpha; Nrf2, nuclear factor 
(erythroid-derived 2)-like 2; Sirt3, Sirtuin 3; MnSOD, manganese 
superoxide dismutase; mtROS, mitochondrial reactive oxygen 
species. 
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My study demonstrated that high glucose-induced E-cadherin 
repression increases migration through the expressions of EZH2 
and Snail. High glucose specifically induces the recruitment of PRC2 
to the E-cadherin promoter, where high glucose triggers ROS 
production to promote either the activation of JNK-mediated 
cleaved Notch or PI3K/Akt signaling pathways. Moreover, high 
glucose pretreatment improved the migratory ability of the 
transplanted hUCB-MSCs to the wound site, which facilitates tissue 
regeneration. Therefore, I strongly suggest that pre-activation by 
high glucose promotes the therapeutic capability of hUCB-MSCs 
for clinical skin wound healing models. 
Next, the observations presented here indicate that E2 is an 
attractive candidate with the potential to maintain mtROS 
homeostasis through ERα-induced Nrf2 and Sirt3 signaling under 
high glucose conditions. In addition, E2-induced mtROS reduction 
affects cytoprotection by decreasing autophagic cell death in 
hUCB-MSCs. Consistent with in vitro results, transplantation of 
hUCB-MSC with E2 treatment increases skin wound healing and 
angiogenesis, thus therapeutic efficiency ultimately can be 
increased. Therefore, I propose E2 in stem cell therapy to prevent 
and treat diabetes-related diseases in postmenopausal patients in 
order for new therapeutic options in the future. 
In conclusion, this study demonstrated that 1) high glucose-
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induced ROS production activates E-cadherin repression through 
the interplay between Snail and EZH2, which leads to hUCB-MSC 
migration, 2) E2 has a protective effect on high glucose-induced 
mtROS generation via ERα-dependent MnSOD activation via Nrf2 
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포도당은 영양소 대사 조절을 위한 필수 요소이며 줄기세포의 항상성 
조절 및 운명 결정과 행동에 중요한 역할을 한다. 그러나 포도당의 
농도가 높으면 고혈당 합병증의 주요 원인으로 알려져 있는 
활성산소종을 과잉 생성하게 된다. 이전 연구자들은 산화 스트레스, 
특히 활성산소종 함량이 줄기세포의 이주능에 영향을 미친다고 보고했다.  
줄기세포의 운명 결정은 분화능, 증식능, 이주능에 관여하는 유전자에 
의해 조절된다. 17β-Estradiol (E2)은 에너지 항상성 및 포도당 신진 
대사의 중요한 조절 인자이므로 고포도당에 의해 발생되는 대사 장애의 
예방 및 치료에 적합한 표적으로 고려될 수 있다. 그러나 고포도당이 
줄기세포 기능에 어떤 역할을 하는지 정확한 분자생물학적 기전은 
알려져 있지 않으며, E2가 고포도당에 의해 유도되는 활성산소종을 
어떻게 조절할 수 있는지 알려져 있지 않다. 따라서 본 연구는 1) 
고포도당이 줄기세포 이주능에 미치는 영향과 줄기 세포 행동을 
조절하는 기전과 2) 고포도당이 유도하는 산화 스트레스에 E2가 미치는 
영향을 조사하여 궁극적으로 줄기세포 치료 효율을 향상시키는 방법을 
제시하기 위하여 수행되었으며, 결과는 아래와 같다.  
1. 고포도당 처리 (D-글루코오스)에 의해 줄기세포의 이주능을 
증가시켰다. 또한 고포도당 처리는 세포 부착 단백질로 잘 알려진 E-
cadherin 발현을 감소시켰고, cleaved Notch, Snail, EZH2의 발현을 
증가시켰다. 고포도당 환경은 Snail과 EZH2 경로 활성을 통하여 E-
cadherin의 발현을 억제시켰는데, 이는 Snail과 EZH2는 각각의 경로 
활성을 통해 촉진되었다. 또한 고포도당은 세포 내의 활성산소종을 
증가시켰으며, 이는 JNK나 PI3K/Akt 신호 전달을 활성화 시켰다. 
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고포도당에 의해 유도된 JNK의 활성은 γ-secretase를 활성화시켜 
Notch 단백질이 잘리도록 유도하였으며, 잘려진 Notch는 핵으로 
전이되었다. 핵에서 Snail은 고포도당에 의해 PRC2와 결합하고, E-
cadherin의 프로모터 내 E-box와 결합하여 E-cadherin의 발현을 
감소시켰다. 마우스 상처 치유 모델에서 고포도당의 전처리는 
줄기세포의 상처 치유 효과와 이식의 생착률을 증가시켰으며, 이러한 
효과는 Snail과 EZH2의 발현이 억제된 줄기세포에 고포도당 전처리에 
의해 억제되었다. 따라서 고포도당에 의해 증가하는 활성산소종은 
Snail과 EZH2의 증가를 통해 E-cadherin을 억제함으로써 줄기세포의 
이주능을 촉진시켰다. 
2. 고포도당 처리는 줄기세포내 미토콘드리아 활성산소종을 
증가시켰으며, 자가 탐식 관련 단백질인 Beclin1의 발현과 LC3-
II/LC3-I의 비율을 증가시켰고, 세포 생존력을 감소시켰다. 대조적으로, 
E2 처리는 고포도당에 의해 유도된 미토콘드리아 활성산소종을 현저히 
감소시켰고, 이어서 세포 생존 능력을 회복시켰다. 또한 고포도당 
상태에서 E2의 처리는 에스트로겐 수용체 알파를 핵으로 전이시켜 
Nrf2 발현을 촉진시켰다. 핵 내의 Nrf2 증가는 Sirt3의 발현을 
유도하고 MnSOD의 탈아세틸화를 통한 활성을 촉진시켰다. 그러나 
고포도당은 Nrf2의 핵 전이를 하향 조절함으로써 미토콘드리아 
활성산소종을 증가시켰고, 이는 Sirt3를 감소시켜 MnSOD의 아세틸화를 
촉진시켰다. 난소 절제 당뇨병 마우스 모델에서, E2를 주입한 마우스의 
피부 상처에 줄기세포를 이식하였더니 피부 상처의 세포 생착률 및 치료 
효과를 향샹시켰다. 그러나 에스트로겐 수용체 알파의 발현이 억제된 
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줄기세포를 이식 받은 마우스는 세포의 생착률 및 상처 치유 효과가 
감소되었다. 또한 난소 절제 당뇨병 마우스에 E2를 주입한 후 
줄기세포를 이식한 마우스는 에스트로겐 수용체 알파의 발현을 억제한 
줄기세포를 주입한 마우스에 비해 혈관신생효과가 뛰어났다. 따라서 
세포 내 E2에 의해 유도된 에스트로겐 수용체 알파에 의한 Nrf2 및 
Sirt3의 증가 및 MnSOD 활성화에 의해 고포도당이 유도한 
미토콘드리아 활성산소종으로부터 보호되었다. 
결론적으로 1) 고포도당은 Snail과 EZH2의 신호전달 경로를 통한 
E-cadherin을 억제 함으로써 인간 제대혈 유래 중간엽 줄기세포의 
이주능을 향상시켰다. 2) E2는 에스트로겐 수용체 알파를 통해 
MnSOD를 활성화 시킴으로써 고포도당이 유도한 미토콘드리아 
활성산소종을 감소시켜 인간 제대혈 유래 중간엽 줄기세포의 생존 
능력을 회복시켰다. 이러한 연구 결과를 바탕으로 고포도당에 의해 
유도되는 산화 스트레스를 조절 기전을 확립한다면 줄기세포 치료제의 
기능과 치료효과를 개선시킬 수 있을 것이다. 
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